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Abstract 
 
 
Aggregating human exposure to chemicals – An overview of tools and methodolo-
gies 
 
Available computer models for estimating the exposure to substances from multiple con-
sumer products are not suited for this task. Consumers are daily exposed to chemical sub-
stances from consumer products. The level of this exposure has to be assessed to evaluate 
the consequences of exposure to a substance for public health. Considering that a sub-
stance may be contained in several consumer products (for instance, aromatic substances, 
flame retardants and softeners), the contribution of these products to the total exposure 
will have to be added up to determine the aggregate exposure. Aggregate consumer (non-
food) exposure is not routinely evaluated in European assessment frameworks. This re-
port examines to what extent available computer models are suited for evaluating aggre-
gate exposure to consumer products. A method for performing aggregate exposure as- 
sessment is also described. 
 
 
Key words: consumer, exposure, aggregate, risk, substances 
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Rapport in het kort 
 
 
Blootstelling aan chemische stoffen vanuit verschillende consumentenproducten 
 
Dagelijks staat de consument bloot aan chemische stoffen die zijn verwerkt in verschil-
lende (non-food) producten. Om de gevolgen voor de volksgezondheid te kunnen beoor-
delen moet in de eerste plaats de blootstelling bepaald worden. De optelsom van de totale 
(geaggregeerde) blootstelling aan een stof uit verschillende consumentenproducten (denk 
bijvoorbeeld aan geurstoffen, vlamvertragers, weekmakers) moet kunnen worden vast-
gesteld. 
Dit rapport kijkt in welke mate bestaande computermodellen geschikt zijn om geaggre-
geerde blootstelling aan chemische stoffen uit consumentenproducten te bepalen. Op dit 
moment berekenen de Europese beoordelingskaders deze geaggregeerde consumenten-
blootstelling (non-food) nog niet routinematig. Als eerste aanzet tot het opvullen van dit 
hiaat beschrijft dit rapport een methode waarmee een dergelijke geaggregeerde blootstel-
lingsbepaling kan worden uitgevoerd.  
 
 
Trefwoorden: chemische stoffen, geaggregeerde blootstelling, consumentenproducten  
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Glossary 
 
 
The main part of this glossary is adopted from the IPCS Risk Assessment Terminology1  
 
absorption factor 
Percentage or fraction of an external exposing mass that is taken up systemically 
(uptake). 
acute exposure 
 A contact between an agent and a target occurring over a short time, generally less 
than a day. (Other terms, such as ‘short-term exposure” and “single dose,’ are also 
used.) 
aggregate exposure 
The total exposure that arises from multiple sources via different pathways and 
routes. 
chronic exposure 
Multiple exposures occurring over an extended period of time or over a signifi-
cant fraction of a human’s lifetime. 
cumulative exposure 
The total exposure to multiple chemicals that have a common mechanism of ac-
tion.  
dose 
The amount of agent that enters a target after crossing an exposure surface. If the 
exposure surface is an absorption barrier, the dose is an absorbed dose/uptake 
dose (see uptake); otherwise, it is an intake dose (see intake).  
deterministic model 
A mathematical representation of a system in which the input data needed to 
evaluate a particular state of the system, are represented by single (point) values. 
exposure factor 
Value for a parameter that determines the level of exposure, such as food intake 
rate, consumer product use characteristics, anthropometric data. 
exposure pathway 
 The course an agent takes from the source to the target. 
exposure route 
The way in which an agent enters a target after contact (e.g., by ingestion, inhala-
tion, or dermal absorption). 
exposure scenario 
A combination of facts, assumptions, and inferences that define a discrete situa-
tion where potential exposures may occur. These may include the source, the ex-
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posed population, the time frame of exposure, microenvironment(s), and activi-
ties. Scenarios are often created to aid exposure assessors in estimating exposure. 
hazard index 
 Risk ratio of the dose from exposure to the reference dose.  
intake 
The process by which an agent crosses an outer exposure surface of a target with-
out passing an absorption barrier, i.e., through ingestion or inhalation 
Margin of exposure (MOE) 
 The ratio of the no-observed adverse-effect-level to the estimated exposure dose. 
probabilistic model 
A mathematical representation of a system in which the input data needed to 
evaluate a particular state of the system, are represented by distributions of values. 
reference dose 
A numerical estimate of a daily oral exposure to the human population, including 
sensitive subgroups such as children, that is not likely to cause harmful effects 
during a lifetime. RfDs are generally used for health effects that are thought to 
have a threshold or low dose limit for producing effects. 
risk index (RI) 
The quotient of the margin of exposure (MOE) and the acceptable margin of ex-
posure (the margin of exposure incorporating the uncertainty factors).  
source 
 The origin of an agent for the purposes of an exposure assessment. 
subchronic exposure  
Multiple or continuous exposures lasting for approximately ten percent of an ex-
perimental species lifetime, usually over a three-month period. 
toxicity equivalent (TEQ) 
Contribution of a specified component (or components) to the toxicity of a 
mixture of related substances. 
time profile 
A continuous record of instantaneous values over a time period (e.g., exposure, 
dose, medium intake rate). 
uncertainty factor 
Uncertainty factors are intended to account for (1) the variation in sensitivity 
among humans; (2) the uncertainty in extrapolating animal data to humans; (3) the 
uncertainty in extrapolating data obtained in a study that covers less than the full 
life of the exposed animal or human; and (4) the uncertainty in using LOAEL data 
rather than NOAEL data.   
uptake (absorption) 
The process by which an agent crosses an absorption barrier. 
use pattern 
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Specification of the use of a consumer product in terms of use frequency, amount 
of product used etc. 
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Summary 
 
 
In this report an inventory was made of techniques and tools that are available to aggre-
gate the human exposure to chemicals from different sources and along different path-
ways and routes. In the first chapter a brief summary of the considerations that apply to 
aggregation was given. In the second chapter an overview of existing software tools that 
assess the human exposure from different sources and along different pathways, is pre-
sented. It is pointed out that the level of detail, with which aggregation is done, should be 
dictated by the scope and purpose of the assessment. Demands for a first tier, screening 
type of assessment on the required level of detail are much lower than those of an as-
sessment that has to give a realistic quantification of the variation of the exposure in a 
population. Whatever the scope the assessment, however, the aggregation should be 
based on a person oriented approach: exposure profiles should be constructed for a single 
person, (may he represent the entire population or be a realistic model of a person in the 
population) as this is the only way to ensure the consistency of exposure profile in the 
sense that no unrealistic or unrepresentative combinations of exposure are added in the 
aggregation. 
In spite of the fact that the need for doing aggregate exposure assessments is increasingly 
acknowledged, the only area in which aggregation techniques are fully implemented and 
made use of, is the field of exposure assessment to pesticides in the USA. This on the 
mandate of the US Food Quality Protection Act. The Calendex, CARES and LifeLine 2.0 
software programs, described in detail in section 2.2, enable the assessor to estimate ex-
posures arising from different sources, such as tap water, food residues and household 
products to be aggregated in a consistent manner. Tools developed in other fields, in par-
ticular the assessment of human exposure to chemicals released as waste into the envi-
ronment, generally do consider different pathways of exposure and sometimes allow for 
the aggregation (addition) of the exposures along these pathways, but do so in a crude 
manner, not enforcing the consistency and representativeness of the constructed exposure 
profiles. The results obtained by these methods should as a rule only be used as screening 
of upper boundaries or average values of the population exposure (depending on the 
choices of input parameters, e.g. probable or conservative values). 
Section three focuses on the more specific area of the assessment of human exposure to 
chemicals in consumer products. Exposure to chemicals may arise from different prod-
ucts at different occasions. To account for all these contributions, similar methods as de-
scribed for the general aggregation of exposure may be used. 
There is a number of specialized software tools available for the assessment of consumer 
exposures, but none of these implements or facilitates doing aggregate assessment.  
The general procedure for aggregation of exposures given in chapter 1 was adapted to the 
Page 14 of 71  Report 630700001 
 
case of consumer product exposure. Again, the detail with which such a scheme should 
be implemented depends on the scope and purpose of the assessment. Approaches at in-
creasing level of detail were sketched and illustrated with a simple example. The gained  
insight in the exposure in proceeding to higher tiers comes at the cost of rapidly increas-
ing data demands and complexity of the assessment.  
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Introduction 
 
 
Humans may be exposed to chemicals at different occasions and in a number of ways. 
Chemicals may be released into the environment during production or due to the disposal 
of products. After release these chemicals may disperse into residential air, tap water and 
food stuff and may be contacted by people via inhalation and ingestion. Alternatively, the 
chemical may be contained in materials and consumer products, and users of these mate-
rials and products may be exposed to the chemical by inhalation, dermal contact and in-
gestion. To assess the total exposure to chemicals all the emission sources of the chemical 
and all the ways in which a human can be exposed have to be taken into account.  
To assess the total human exposure to a chemical, all the contributing sources, pathways 
and routes should be taken into account; that is, the assessment should aggregate all these 
contributions. 
In this report, aggregation of the exposure is defined as the addition of the contributions 
of all the sources, pathways and routes (oral, dermal and inhalation) from and via which 
the exposure to a single chemical takes place.  
Aggregate exposure is to be distinguished from cumulative exposure, which is, in this 
document, understood as the exposure to substances with the same mechanism of action.  
Aggregation of the exposure in risk assessments is not common practice.The risks from 
chemical exposure are often assessed for different sources and exposure pathways sepa-
rately. In such a procedure, there is always a possibility that the risk of chemical exposure 
is underestimated.  
The need to consider aggregate exposure in assessments is increasingly acknowledged. 
The US Food Quality Protection Act2 mandates the evaluation of both aggregate and cu-
mulative risks associated with pesticide use, therefore a lot of experience is already 
gained in the USA. 
Special attention is paid in this report to the aggregate exposure of chemicals from multi-
ple consumer products. Consumer products constitute a potentially important pathway for 
a variety of chemicals such as flame retardants, phthalates, pesticides and VOCs3,4,5 . Ex-
posure assessments for chemicals released from consumer products are regularly done for 
the authorization of substances or the evaluation of product safety. Mostly these assess-
ments are performed on a per product basis and the exposures arising from other products 
containing the same substance are neglected. Obviously, this approach may yield an un-
derestimation of the risks involved. To account for the exposures from several products 
containing the same substance of concern, similar techniques as for determining aggre-
gate exposure can be employed. 
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In this report an inventory of tools and methodologies for aggregating exposure, is made. 
Basic principals and considerations of aggregation in exposure and risk assessments are 
briefly discussed in chapter 1. Subsequently, in chapter 2, an overview and a discussion 
of computer exposure estimation tools that, in one way or another, implement aggrega-
tion is given. The applicability of the various tools to determine aggregate exposure of 
consumer to chemicals in consumer products is discussed, when appropriate. 
In chapter 3 the discussion is focused on the human exposure to chemicals in consumer 
products. Specific considerations that pertain to aggregate exposure assessments for a 
chemical contained in multiple consumer products are given in section 3.1. In section 3.2 
specialized computer tools modeling the human exposure to chemicals in consumer prod-
ucts are briefly reviewed and their applicability in aggregate exposure assessments is dis-
cussed. 
In section 3.3 we sketch in some detail how an aggregation of the exposures from differ-
ent products may be performed for different required levels of detail. This framework is 
illustrated in section 3.4 with an example, in which the aggregate exposure is estimated 
for a combination of cleaning products containing the same (hypothetical) substance. 
In the discussion of different exposure (software) tools that are available, focus will be on 
the way they deal with the aggregation of the exposure. More general comparison studies 
of these tools have been presented elsewhere6,7,8. It is not the intention of this study to 
duplicate that work. 
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1. Introduction  
 
 
1.1. Aggregate exposure assessment 
 
Assessments of human exposure to chemicals may be conducted for different reasons and 
with different objectives. The purpose of an assessment may be to get a rough, order-of-
magnitude estimate of the maximal level to which a population is exposed to a chemical, 
or it may be to obtain a detailed insight into the distribution of exposure over and within 
different subpopulations in order to quantify the effects of the exposure and to analyse the 
relative contributions of different sources, pathways and routes to the expected health ef-
fects in the population.  
Usually, different levels of detail and sophistication of assessment are combined in a 
tiered approach (see for example9,10). In such an approach, the first step often consists in a 
very crude, quasi-quantitative estimate (often referred to as a tier 0 estimate) in which a 
number of worst case assumptions is made regarding the exposure of a population (e.g. 
the fraction of the total production tonnage of a chemical that ends up in the population is 
conservatively assumed to be very large). If a level of concern is exceeded, stepwise 
more realistic and detailed approaches will be used, requiring real data or more refined 
assumptions, until a final conclusion can be drawn.  
The required level of detail of the assessment determines how the exposure will be as-
sessed and, in particular, how the aggregation has to be performed. 
Irrespective of the required level of detail of the assessment, however, the aggregation 
should adhere to a person-oriented approach to maintain consistency. In an assessment, 
the exposure for a hypothetical individual is estimated. If exposure potentially occurs via 
different pathways, the combination of the pathways considered in the assessment should 
represent a realistic situation for the individual considered. Pathways that in reality would 
never co-occur, should not be combined (for example: the occupational exposure of an 
industrial worker should not be combined with the hand-mouth contact exposure of a 
toddler). Unrealistic combinations of exposure pathways are avoided by starting an as-
sessment with the selection of an exposed individual and constructing a realistic exposure 
profile for this person. 
Acknowledging the fact that aggregating the exposure should be person-oriented, there 
still remains the question what this person represents. 
It may be that this person is entirely hypothetical and stands model for a high-exposed, 
sensitive subpopulation (e.g. industrial workers or children). Or it can be that this person 
is intended to be a realistic model of a real person in the population under consideration.  
The first case is habitually employed in lower tier assessments. The assessment boils 
down to a deterministic (point) calculation using conservative input values for all expo-
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sure parameters. The outcome of the assessment will be an estimate of the exposure that 
is very likely to be an upper bound of the exposures that occur in reality. This high bound 
exposure may be compared to some acceptable level to judge whether there is any reason 
for concern associated with the exposures to this substance. If there is reason for concern 
(or at least adverse health effects can not be excluded in this first step), the assessment 
will have to be refined by additional data collection or more detailed and advanced  
modeling.  
The second approach is usually encountered in detailed, probabilistic population exposure 
assessments. The assessment is repeated for a large number of similarly modeled indi-
viduals that together represent the population of interest. Usually the modeled individuals 
are randomly constructed from elaborate (distributional) data on the population such as 
anthropometric, social status and time activity data. The integration of the individual ag-
gregate exposures to population exposures is done, in most cases, by Monte Carlo simula-
tion. 
 
Another important consideration when aggregating exposure is the toxicity of the sub-
stance under study. The timescale on which the exposure is assessed should be consistent 
with the exposure durations for which health effects are observed. If acute toxicity is a 
critical endpoint, the assessment should estimate exposures on acute timescales (e.g. of 
one day). If, on the other hand, only chronic exposures have to be considered, the assess-
ment may estimate one year average doses, or a similar long period average. 
In the case of acute exposures, details of the temporal and spatial correlations of the ex-
posure events become important, since, for instance, the simultaneous occurrence of two 
or more exposures along different pathways may in combination lead to peak exposures 
exceeding some tolerable level, although each exposure event individually may remain 
below this level (see Figure 1). If, on the other hand, longer (chronic or sub-chronic) 
timescales are considered, adding the average exposures of the different pathways with-
out explicit reference to the temporal correlations between the exposure events, may be 
acceptable. 
In determining longer time averages from detailed exposure profiles (such as weekly or 
yearly averaged profiles from daily profiles) it should be noted that the time averaging of 
a highly variable profile may depend not only on the length of the averaging interval but 
also on the begin and end time of the averaging interval. The value of a weekly averaged 
exposure may be dependent on whether the averaging interval ranges from Monday to 
Monday or from Sunday to Sunday, for example.  
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Figure 1 Combining exposure profiles that are correlated in time. The aggregate expo-
sure of events 1 and 2 may lead to exceeding of a norm for acute toxicity whereas the ex-
posure profiles separately remain both below this level and the long time average of the 
aggregate exposure remains below the level of concern of the chronic exposure. 
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Besides the timescale on which the exposure assessment should be based, also the route 
of exposure (e.g. inhalation, dermal or oral exposure) is determined by the toxicological 
profile of the substance under consideration. If adverse health effects are observed for a 
specific route (e.g. dermal specific toxicity such as eczema), the exposure should be as-
sessed for this route separately from other routes, and the risk would be assessed for the 
route of concern explicitly.  
More generally, health effects may differ among routes of exposure. In this case, aggre-
gation should be performed first for each individual route and, after this per-route evalua-
tion, the aggregate exposures per route should be integrated to a total aggregate exposure. 
In the summation of the exposure over different routes, the usual considerations for inte-
gration over different routes apply. The exposures should be expressed in a metric that is 
common for the different routes and subsequently be added.  
The US EPA Office for Pesticide Programs suggests the use of two risk metrics the ‘total 
margin of exposure’ (MOEtot), and the ‘aggregate risk index’ (ARI)11.  
 
The MOE is calculated by dividing the No-Observed-Adverse-Effect Level (NOAEL) by 
the estimated exposure for the considered route.  
The MOE for each route is compared with an UF (typically a factor of 100) which serves 
as a standard when ascertaining whether a given exposure is acceptable.  To combine dif-
ferent MOEs into one, one uses the following equation: 
 
1 2
1
1 1 1...
tot
n
MOE
MOE MOE MOE
=
+ + +
 
 
where MOE1, MOE2, ….MOEn represent route specific (e.g. oral, dermal, inhalation), 
MOEs.  
This approach is only valid when the uncertainty factor for each of the different routes is 
the same, so the MOEtot can be assessed by comparing it to this uncertainty factor. 
 
If this is not the case, the constituting MOEs should be normalized into a ARI first by di-
viding each MOE by its corresponding UF: 
 
 
MOEARI
UF
≡  
 
now, the total ARI is obtained by: 
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1 2
1
1 1 1...
tot
n
ARI
ARI ARI ARI
=
+ + +
 
Both approaches are equivalent if the UFs are the same for all routes. 
Other methods to combine exposures via different routes make use of Toxicity Equiva-
lency Factors (TEFs)12(used for cumulative exposure assessment) or the Hazard Index 
(HI)13 
 
Aggregation of the chemical exposure from different sources is routinely done in dietary 
intake studies, where a chemical may be contained in widely different food products and 
commodities and the total exposure is from the intake of a daily varying selection of these 
products and ingredients. A procedure commonly applied in these cases, is the construc-
tion of daily consumption patterns for a population of potentially exposed individuals 
combining data on food consumption surveys and measurements of chemical levels in 
foodstuff. From daily consumption patterns in a population, the total daily intake of a 
chemical follows from the addition of the intake over all consumed food products. From 
the individual daily intakes, long term averages and distributions of the exposure within 
the population follow. 
 
Aggregating the chemical exposure from multiple sources could follow a similar proce-
dure. A typical aggregate exposure assessment could take the following steps: 
1. identify the sources and pathways of exposure. 
2. identify and define the populations of concern. 
3. construct the exposure profiles for individuals taken from these populations 
4. aggregate the exposure per route for each individual from his exposure profile, on 
the timescales that are required for the assessment as dictated by the toxicological 
end points of the substance under consideration (e.g. daily intakes per route). 
5. construct appropriate time averages and population exposure measures from the 
individual exposure profiles. In this step, for instance, specific percentiles of the 
exposure within a population are determined, or sub-chronic or chronic exposures 
are derived from daily exposure values.  
6. integrate the exposures over the different routes, using an appropriate dose metric. 
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2. Human Exposure Assessment Computer Tools 
 
 
A number of the models and approaches used in various fields of chemical exposure as-
sessment have been implemented in computer programs that are publicly available. In 
this section we will give an overview and a brief description of some commonly used 
tools and discuss to what extent aggregation has been implemented. For non-European 
tools, the applicability of the tool to the European situation is discussed. 
We included the following programs in this review: 
 
• CalTOX 
• CSOIL 
• E-FAST   
• EUSES  
• Calendex 
• CARES 
• LifeLine 
 
The only criteria for inclusion in this list were that the tools aid in the estimation of hu-
man exposure to chemicals and that they in one way or the other include multiple sources 
and pathways of exposure. As already remarked, the area of application and the level of 
sophistication vary widely among the tools. A detailed comparison between the different 
tools was therefore not deemed useful.  
Several reports exist on the comparison and description of computer tools that can be 
used to perform exposure assessment5,6,7. We do not aim at repeating the work done in 
these reports. We will only briefly describe each of the computer tools and discuss how 
they implement aggregation of the exposure. In addition, we will indicate, if appropriate, 
to what extent the tools are capable of dealing with human exposure to chemicals in con-
sumer products.  
The modeling tools can be divided into two distinct groups. 
The first group of tools (CalTOX, CSOIL, E-FAST, EUSES, SHEDS) model the expo-
sure of humans to chemical emissions into the environment by industrial waste or dis-
posal of chemicals and subsequent dispersion into contact media and, finally into the per-
sonal environment. These tools will be described in section 2.1. 
The second group (CALENDEX, CARES, LifeLine) is a number of tools that are used 
exclusively for the evaluation of pesticides that are used both in agriculture and in resi-
dences. Tools in this group differ in the level of complexity and the number of pathways 
examined.  
This group of tools will be described in section 2.2. 
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2.1 Programs modeling human aggregate exposure to 
chemicals from environment 
 
2.1.1 CALTOX 
General description 
CalTOX is a risk evaluation model that has been developed at the Berkeley National 
Laboratory with the support of the US EPA National Exposure Research Laboratory. It is 
designed to assist in the assessment of human exposures and risks from continuous re-
leases of hazardous wastes into multiple environmental media, i.e. air, soil and water. 
Soil is assumed to be the primary environmental medium contaminated. From the con-
taminated soil, multiple pathways of human exposure are considered, such as exposure 
via contaminated tap water, soil, outdoor air, indoor air and food. 
CalTOX calculates chronic daily intakes (route specific and integrated). These chemical 
exposure doses can be used to quantify health risks14. 
The models have been implemented in Microsoft Excel and therefore need this program 
to run. 
 
Exposure calculations 
CalTOX has two main modeling components:  
• a multimedia transport and transformation module to estimate the time-varying 
distribution of contaminants among different environmental compartments, using 
fugacity and fugacity capacity data for the modeled chemicals. 
• a multiple pathway exposure model, which calculates how much of a chemical 
reaches the body using environmental concentration and contact factors (e.g. 
breathing rate).  
The primary emission is assumed to be into the soil. From the soil concentration human 
exposure may arise along a number of pathways such as:  
• inhalation exposures indoors 
• inhalation in shower/bath 
• inhalation outdoors 
• inhalation particles indoors 
• transfer of soil dust to indoor air 
• use of ground water as tap water 
• ingestion of tap water 
• ingestion of crop 
• ingestion of homegrown meat 
• ingestion of locally caught fish 
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• direct soil ingestion 
• breast milk ingestion by infants 
 
For each of these pathways, daily intake rates of the contacting medium (air, tap water, 
crop, meat etc.) that characterize the exposed person must be specified. The user can cus-
tomize the exposure profile of the exposed person by in- or excluding pathways. 
A total daily intake for the exposed person is obtained by aggregation over the different 
exposure pathways. The model outputs are averaged daily (chronic) doses. 
CalTOX does not include exposures from chemicals in consumer products. 
 
Data needs 
The user has to specify a number of different sets of data. These are: 
• chemical data (basic physical chemical data, partition coefficients to different en-
vironmental compartments, biotransformation data, half life times in various 
compartments) 
• landscape properties (boundary layers, water and air content in soil, porosity 
sediment, and more) 
• human exposure factors (intake rates of various contacting media, body weight 
etc.) 
For all of these, CalTOX provides default databases within the Excel sheet, but the data 
may be manually overwritten. Properties of a number of chemicals are given, as well as 
landscape data for US states and US average data. Default human exposure factors for 
different groups in the population are given. 
 
Aggregation 
CalTOX aggregates the exposure over different pathways. The aggregation is done by 
constructing an exposure profile (customizable by the user) for the modeled person by 
specifying the routes and pathways via which the person is exposed. Variations within the 
population and uncertainty about the exact value of the input parameters can be ac-
counted for by supplying distributions as input. Variations within the population in expo-
sure profile (i.e. different persons may be exposed via different pathways) can not be as-
sessed within a single simulation. As a consequence, aggregation is performed only for 
distinct groups (with specific, fixed exposure profiles) in a single assessment. Thus it is 
not possible, for example, in the program to accommodate in one simulation the exposure 
of children through the intake of breast milk and the exposure of an adult population via 
fish and meat intake. These two populations have to be simulated in separate model runs. 
Another limitation of the aggregation in the CalTOX program is the fact that the program 
does not aggregate over multiple releases into the environment. Only the exposure arising 
from one source at a time can be assessed. 
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Daily intake data are given as year averaged values. Temporal variations in intake rates 
(for instance, day to day or seasonal variation in meat or fish intake rates) can not be ac-
counted for, limiting the timescale of the CalTOX assessments to chronic (that is, one 
year (or longer) average) exposures.  
 
Applicability to European situation 
The CalTOX tool is fully customizable. The sets with default input data on landscapes 
and human exposure factors are only valid for the US, but may be overwritten with data 
adapted to a (non-US) region of application. 
 
2.1.2 CSOIL 
General description 
CSOIL is an aggregate model that estimates the total human uptake of a soil contaminant. 
The conceptual model (that is, the set of equations) has been developed at the Dutch Na-
tional Institute for Public Health and the Environment (RIVM) and it has been imple-
mented in the commercially available RISC-HUMAN tool (http://www.risc-site.nl). The 
tool allows only for deterministic calculations15. 
 
Exposure calculations 
From the user-specified soil concentration of a chemical the model calculates human ex-
posure in a number of steps. First, the distribution of the chemical over different phases in 
soil (solid, liquid and gas) is determined. Next, the concentrations in contact media are 
estimated (air flux into indoor and outdoor air, accumulation in crops, permeation into tap 
water and the concentration in bathroom air). And finally, human exposure is assessed. 
Pathways include: 
• ingestion of dust and soil 
• dermal contact with dust and soil 
• inhalation of soil particles 
• ingestion of contaminated crop 
• intake of tap water 
• vapour inhalation during showering 
• dermal contact during bathing and showering 
 
Data needs 
CSOIL needs a set of basic physical chemical properties of the substance of concern such 
as molecular weight, water solubility, Kow, vapour pressure, bioconcentration factor. In 
addition to these data, toxicological information has to be provided. For a number of pa-
rameters such as soil properties, and anthropometric data, defaults are suggested. 
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Aggregation 
The total uptake of the chemical in the body is determined by summation of the contribu-
tions of the different pathways and routes using (default) intake rates and absorption fac-
tors for each route and contact medium. From this total intake an average lifelong daily 
(aggregate) intake is determined. Distributional calculations are not supported although 
the model distinguishes between two different subpopulations: adults and children for 
which assessments are performed separately. 
 
2.1.3 E-FAST 
General description 
E-fast is an acronym for ‘Exposure and Fate Assessment Screening Tool’. It is a screen-
ing level computer tool that allows the user to generate estimates of chemical concentra-
tions in water to which aquatic life may be exposed and estimates of human inhalation 
and ingestion exposures resulting from chemical releases to air, water and land. E-FAST 
can also be used to assess inhalation and dermal exposures to chemicals that may result 
from use of certain types of consumer products. The program was developed by Versar 
Inc., to support the US Environmental Protection Agency (EPA) assessments of potential 
exposures to new chemicals which are submitted to EPA under the Toxic Substances 
Control Act. 
The program does not allow for probabilistic exposure evaluations, but considers differ-
ent age groups within the population16. 
 
 
Exposure calculations 
1. Indirect human exposure via the environment 
In assessing the indirect human exposure via the environment E-FAST considers as expo-
sure pathways the inhalation of air, the ingestion of drinking water and fish consumption. 
To arrive from surface and ground water concentrations to concentrations in tap water the 
effects of purification are estimated. Intake of the chemical is determined by combining 
this concentration with drinking water intake rates.  
The estimate of human exposure to the chemical by intake of fish combines estimates of 
the surface water and ground water concentrations with the estimation of the bioaccumu-
lation of the chemical in fish and assumptions on the fish consumption.  
For inhalation exposures, E-FAST uses simple, conservative methods to estimate ambient 
air concentrations that may result from industrial air emissions. Using this estimate of the 
ambient air concentrations, an average inhalation intake (either over 30 (ADDpot) or  
75 years (LADDpot)) is determined. 
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2. Exposure to consumer products 
E-FAST estimates potential inhalation exposure and potential and absorbed dermal expo-
sure to chemicals in certain types of consumer products. E-FAST implements the same 
calculations as the MCCEM, SCIES and DERMAL tools.  
Consumer exposure scenarios include: 
• general purpose cleaner 
• interior latex paint 
• fabric protector 
• aerosol paint 
• liquid laundry detergent 
• solid air freshener 
• bar soap 
• used motor oil 
• user defined scenarios 
 
Data needs 
The user has to provide data on: 
• Releases to air, water and land 
• Frequencies and durations of release events 
• Removal in wastewater treatment 
• Removal in drinking water treatment 
• Fractions of the chemical that will sorb to sludge 
• Bio concentration factor 
• Potential for migration to ground water from land disposal 
• Removal by air pollution control devices or by incineration 
• Weight fraction in consumer products 
• Physico-chemical parameters 
• Anthropometric data (body weight, inhalation rate). The program provides de-
faults for different age categories that can be overwritten. 
 
E-FAST includes a database of stream flow values obtained from the ‘Gage File’ in the 
EPA's STORET (STOrage and RETrieval) system. Necessary stream flows are retrieved 
from this database, on basis of explicit facility name or on Standard Industrial Classifica-
tion (SIC) code. In addition the program contains facility information for over 27.000 di-
rect discharging facilities in the US. 
For many of the input parameters, the program suggests default values.  
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Aggregation 
E-FAST considers the ingestion and inhalation routes of exposure and a number of expo-
sure pathways but the exposures are only reported per pathway and not summed. Hence, 
the model does not aggregate the exposure in the sense defined in this document. 
 
Applicability to European situation 
The tool is especially designed for exposure estimations in the US. The methods can be 
applied to regions outside the US, but the included databases on stream flows and dis-
charging facilities may not be usable or representative. 
 
2.1.4  EUSES 
General description 
Full program name: European Union System for the Evaluation of Substances 2  
(EUSES 2). The development of EUSES was commissioned by the European Commis-
sion to the National Institute of Public Health and the Environment (RIVM) of The Neth-
erlands. The work was supervised by an EU working group comprised of representatives 
of the JRC-European Chemicals Bureau, EU Member States and the European chemical 
industry. TSA Group Delft BV was responsible for programming the system. 
 
The PC program EUSES is designed as a decision-support system for the evaluation of 
the risks of substances to man and the environment. The system is fully described in the 
EUSES documentation and is based on the EU Technical Guidance Documents (TGDs; 
EC-TGD, 2003) for risk assessment of new and existing substances and biocides. 
EUSES allows for a number of different human risk assessments including the assess-
ment of human exposure to chemicals via the environment, humans exposed to chemicals 
via consumer products and humans exposed at the workplace.  
The inhalation, dermal and oral routes of exposure are considered. The tool allows only 
for deterministic calculations. Quantitative evaluations of the uncertainty of and the vari-
ability in the assessments can therefore not be made17,18,19. 
 
Exposure calculations 
EUSES comprises several exposure modules: 
1. Exposure of man via the environment 
With EUSES, first releases to environmental compartments (air, surface water, marine 
water, sediment, soil and groundwater) or the indoor environment are predicted based on 
the volume of the chemical produced, imported or used, the use pattern, and physico-
chemical properties of the chemical. Next, estimates are made of the human intake of the 
chemical via drinking water and food products (root crops, leaf crops, meat, milk and fish) 
and of the exposure via indoor air. The intake rates of the different media are assessed on 
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basis of a standard consumption pattern that represents the total population and these intakes 
via the different pathways are added. Exposures can be estimated both on regional and local 
scales. 
  
2. Consumer Exposure 
To assess the human exposure to chemicals in consumer products, EUSES offers different 
consumer exposure scenarios. One inhalation, two dermal and two oral scenarios: 
• Inhalation: a substance that is released as a gas, vapour or airborne particulate into 
a room (e.g. a component of an aerosol insecticide, a carrier/solvent in a cosmetic 
formulation, a powder detergent). Release may be the result of direct release as a 
gas, vapour or particulate, or by evaporation from liquid or solid matrices. In the 
latter case, the equation represents a worst-case situation by assuming that the 
substance is directly available as a gas or vapour.  
• Dermal a: a substance contained in a medium. This dermal scenario also applies 
to i) a non-volatile substance in a medium used without further dilution and ii) a 
non-volatile substance in a volatile medium. 
• Dermal b: a non-volatile substance migrating from an article (e.g. dyed clothing, 
residual fabric conditioner, dyestuff/newsprint from paper).  
• Oral a: a substance in a product unintentionally swallowed during normal use (e.g. 
toothpaste). 
• Oral b: a substance migrating from food contact materials (e.g. plastic film, 
plastic-coated cups/plates). 
 
 The EUSES scenarios for consumer exposure are based on crude assumptions. Use 
patterns are limited to the amount of chemical that is used or released during use, and the 
frequency of exposure events (i.e. the number of exposure events per year). Details of the 
release and of transport of the chemical are not taken into account. The EUSES scenarios 
are meant to be generic and applicable for a wide range of consumer products rather than 
to give a detailed description of the exposure for a specific consumer product. The risk 
evaluation for more than one consumer product is possible. However, risks are evaluated 
for each product separately, and exposures for different products are not added in the 
program. 
 
3. Worker Exposure 
(Sub)chronic exposure of workers in EUSES is estimated by means of the model EASE, 
implemented in EUSES. In addition acute exposure values can be entered by the user. 
Different scenarios can be assessed for the inhalation and dermal route and for each sce-
nario a total exposure is calculated. EASE is a decision tree type of system. The user 
needs to provide answers on the questions presented by the model. Based on the answers, 
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exposure ranges are assigned, derived from experimental measurements from workplace 
environments. The model accounts for inhalation exposure to vapours, fibres and dust, and 
for dermal exposure. 
 
Data needs 
The program first needs the physical and chemical properties of the substance considered, 
to be provided by the user. 
Second, the different environmental compartments, transport and fate parameters, such as 
partition coefficients, bio concentration factors, degradation and transformation have to 
be specified. For most of these, default data based either on expert judgement or on ex-
trapolation methods are provided. Most of these defaults can be overwritten by the user, 
if better data are available. 
Third, emission rates must be given, the program gives default data based on expert 
judgement for most of these. Finally, in order to evaluate the risks from the exposure to 
the chemical, the user must specify various effects data such as NOAELs and LOAELs 
for different toxic endpoints. 
 
Aggregation 
EUSES considers a number of different exposure pathways and routes, but nevertheless, 
complete aggregation is not implemented in the program.  
The contributions from different pathways of indirect human exposure via the environ-
ment are added by assuming a standard consumption pattern. This consumption pattern 
can be adapted by the assessor to represent other individuals or groups in the population, 
but (inter- and intra individual) variations in consumption patterns (i.e. consumption pat-
terns of children, vegetarians) can not be handled within a single assessment.  
Contributions to the total exposure from consumer products are not added to the human 
exposure via the environment in the program. In addition, the contributions of the expo-
sure from different products are not added. Chemical intakes are evaluated per product. 
Risks are evaluated for each consumer product separately, disregarding the exposures 
from other products and environmental sources or exposures at the workplace.  
Similarly, the exposure at the workplace is treated separately from the other pathways 
and the results are not added to those of the other pathways. And risks are evaluated in 
isolation from any exposures that may occur from other sources, via other pathways.  
We conclude that aggregation in EUSES is implemented in a very limited way, in spite of 
the fact that exposure via different routes and a large number of pathways is considered. 
The program does not integrate all these sources and pathways. The program does not 
deal with variations in exposure profiles. This limits the use of EUSES in aggregate ex-
posure assessments to screening level assessments. 
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2.2 Programs modeling human aggregate exposure to pesti-
cides 
 
This section discusses a number of US pesticide exposure assessment tools. The US Food 
Quality Protection Act (FQPA) mandates that the US Environmental Protection Agency 
evaluate both aggregate and cumulative risks associated with pesticide use. EPA’s Office 
of Pesticide Programs (OPP), which is responsible for regulating pesticide residues in 
food, has developed guidance on aggregate exposure assessments for pesticides11. 
The assessment tools described below implement, in varying extent, the requirements 
posed by the OPP guidance document. 
Aggregate should, according to the OPP guidelines, be performed on an individual basis 
and should maintain the linkages and associations between consumption data and demo-
graphic data. 
The OPP identifies three pathways of exposure of the human population to pesticides:  
• pesticide residues in tap water 
• pesticide residues in food 
• residential exposure resulting from pesticide applications made in and around the 
home and in public places 
 
Food  
Pesticides are used on crops as protection from various pests. Residues of these pesticides 
will end up in raw food commodities and in prepared food. The residue level in the food 
as it is eaten will depend on the composition of the food (which crops are consumed, 
whether tap water with residue levels was used) and the way the food was prepared 
(cooking the commodities and pealing treated fruits and vegetables may reduce residue 
levels).  
A standard method to evaluate dietary intake exposure to residues is to combine known 
levels of pesticide residues in either raw commodities or complete foodstuff with dietary 
studies, constructing daily menus for individuals in a population and estimating popula-
tion exposure using Monte Carlo techniques. Details of the method, specific to each of 
the modeling tools are discussed in the section on the tool concerned.  
In the OPP guidelines it is suggested that the development of aggregate exposure scenar-
ios starts with the food exposure pathway. By using the extensive demographic data in 
the US Census Continuing Survey of Food Intake by Individuals20 (CSFII), the assessor 
constructs a hypothetical population, representative of the food intake of the US popula-
tion. 
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Tap water 
Residues in wells, ground water and surface water are due to pesticide run-off from agri-
cultural application. From these sources, residues will end up in tap water. Exposure will 
arise due to consumption of tap water and dermal and inhalation exposures during show-
ering.  Exposures to pesticide concentrations in drinking water are usually a local or re-
gional phenomenon and will depend on the time of year. The OPP guidance requires that 
these spatial and temporal variations be accounted for in the aggregate exposure assess-
ment. 
Residential exposure 
The OPP guidelines prescribe that exposure assessments for residential and other non-
occupational sources should focus on the US EPA Draft Residential Standard Operating 
Procedures (SOPs)21,22. These consist of a number of fixed use scenarios: 
• lawn care 
• vegetable garden care 
• ornamental plant care 
• tree care 
• pick own fruits/vegetables 
• crack & crevice treatment 
• termite control 
• rodent control 
• pet care 
• outdoor fogger use 
• indoor fogger use 
• indoor treatment 
• paint/wood treatment 
• impregnated materials 
• detergent/hand soap use 
• swimming pool use 
 
These crude, general scenarios specify an amount of product used in the task, and use ge-
neric exposure units such as UnitDose or UnitConcentration, which are units of exposure 
per amount of product used (i.e. dose per kg product used), to estimate total exposure.  
Many of the post-application exposure scenarios defined in the SOPs make assumptions 
regarding the amount of dislodgeable pesticide residues. Dislodgeable residues are those 
residues that may be transferred to the skin as a result of contact and are available for 
dermal absorption or ingestion. Assumptions regarding transfer of dislodgeable residues 
are generally based on the experience and professional judgment of OPP staff from the 
review of monitoring studies. Many of the handler SOPs use unit exposure values from 
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the Pesticide Handlers Exposure Database (PHED) as inputs into the exposure assessment 
algorithms. PHED is a database containing surrogate handler data collected from field 
exposure studies.  
The pesticide exposure of residents will depend on the use pattern, whether a professional 
applicator was hired or not, on the season, and on social status of the resident. The OPP 
suggests that these factors should be accounted for in the aggregate assessments if data 
are available. 
 
The OPP guidelines recommend the use of a number of databases: 
• NHAPS (National Human Activity Pattern Survey) survey on activity pat-
terns23,24. Data from a study conducted for the US EPA in 1992-1994. A large 
amount of data was collected on activity patterns for 9,386 subjects from regions all 
over the US over a 24-hour day. Data include information on race, gender, social 
status, activities subjects were engaged in and for how long, and residence times in 
various microenvironments. 
• NHGPUS (National Home and Garden Pesticide Use Survey) database on pesti-
cide use. 
• AHS (American Housing) database25,26. The American Housing Survey (AHS) 
collects data on the US housing, including apartments, single-family homes, mobile 
homes, vacant housing units, household characteristics, income, housing and 
neighborhood quality, housing costs, equipment and fuels, size of housing unit, and 
recent movers. The national sample covers an average 55,000 housing units. Each 
metropolitan area sample covers 4,100 or more housing units. 
• CSFII dietary surveys (Continuing Survey of Food Intake by Individuals, 1994-
1998)27,28. Data on food consumption habits of US population. It is a 24 hour dietary 
recall study for 2 or 3 days. 
• PHED database on pesticide handling29,30. 
      A database containing voluntarily submitted empirical exposure data for workers 
involved in the handling or application of pesticides in the field; it currently contains 
data for over 2000 monitored exposure events. The system assumes that exposure to 
pesticide handlers can be calculated generically, based on the available empirical data 
for chemicals, as worker exposure is primarily a function of the formulation type and 
the handling activities (e.g., packaging type, mixing/loading/application method, and 
clothing scenario), rather than chemical-specific properties31. 
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2.3. Program by program review 
 
2.3.1  Calendex – Calendar-based dietary and non-dietary aggregate 
and cumulative exposure software system 
Calendex has been developed by Durango Software and distributed by Exponent, inc., 
USA. It was designed specifically to conduct aggregate and cumulative human exposure 
assessments from pesticides, as required by the Food Quality Protection Act (FQPA) of 
199632. 
 
General description 
The Calendex aggregate exposure model estimates human exposure to chemical residues 
in foods and home-based chemical treatments, such as pest control and turf treatments. 
The model assesses acute, short-term, intermediate, or chronic time periods for a large, 
representative sample of the US population and for a wide range of sub populations. The 
model simultaneously accounts for the temporal, spatial, and demographic variation in 
chemical use and chemical users.  
 
Exposure calculations  
1. Dietary exposure 
Calendex uses the database of population demographics and dietary intake data from 
USDA’s CSFII for 1994-96, 1998 to provide a representative sample of the U.S. popula-
tion and user-specified sub populations. Individual intake of specific agricultural com-
modities (e.g. wheat, corn, tomatoes) is derived from the foods-as-eaten intake amounts 
in the CSFII using ‘recipe’ translation factors from the joint USDA/EPA Food Commod-
ity Intake Database (FCID). CSFII statistical weighting factors for the individuals in that 
survey assure that the exposure distributions are representative of the entire US popula-
tion and related subpopulations. 
 
2. Residential exposure 
The residential pesticide exposure calculations are based on the US EPA SOPs for Resi-
dential Exposure assessments, but the user may develop and use his own models. Scenar-
ios include application and post-application exposures and both professional and amateur 
uses. Dermal, inhalation and ingestion routes of exposure are considered. 
 
3. Water exposure 
Pesticide intake are estimated from the daily water intake (from the CSFII survey) and 
the residue values of the pesticide. 
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Data needs 
Calendex includes a large number of databases such as the USDA’s CSFII and the 
USDA/EPA Food Commodity Intake Database (FCID). The user has to provide data on 
the residential use of pesticide products, exposure factors and environmental pesticide 
concentrations. In addition, the user has to specify chemical residue values for the agri-
cultural commodities. 
 
Aggregation framework 
Calendex aggregates using a ‘Calendar Model’ which sets up a schedule of dietary intake 
events and pesticide applications and human contact events in the residential environment 
over a calendar year for a designated individual using Monte Carlo analysis methods. It 
then allows the user to assess the probable aggregate and cumulative exposure for that 
individual on a daily, weekly, multiple-week, or annual basis. These exposure amounts 
are calculated for many thousands of individuals in a user-specified subpopulation (e.g., 
1-2 year olds in the Northeast), and distributions of exposure amounts for that subpopula-
tion are generated and compared to benchmark risk measures (e.g., RfD or NOEL). In 
addition, a critical exposure contribution report is generated for any given segment of this 
distribution (e.g. 99-100th percentile of exposure), showing the relative contribution of 
each pesticide use by exposure route (dietary, inhalation, dermal, and incidental inges-
tion). 
 
Applicability to European situation 
The use of the Calendex software is data intensive. Much of the available data is specific 
for the US-population. Not all of these databases can be adjusted to fit the European 
situation, which severely limits the applicability of the tool outside the USA. 
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2.3.2    CARES- Cumulative Aggregate Risk Evaluation System 
General description 
CARES is designed to conduct complex exposure and risk assessments for pesticides, 
such as the assessments required under the 1996 Food Quality Protection Act (FQPA).  
CARES was originally developed under the auspices of CropLife America in collabora-
tion with consulting companies, the USEPA and US Department of Agriculture (ASDA). 
It has been transferred to the ILSI Research Foundation, where the CARES program and 
source code will continue to be publicly available at no charge.   
 
CARES evaluates aggregate and cumulative human exposures to pesticides for multiple 
route-specific pathways (drinking water, food, residential). Doses are compared with tox-
icity data to quantify human health risks. Timescales of the risk assessment range from a 
single day (acute) to year averaged (chronic). Assessments are population based. The user 
can specify sub populations or make an assessment for the entire US population33,34. 
 
Exposure calculations  
1. Dietary exposure 
The user makes a selection which part of the reference population is to be included and 
which foods will be considered in the assessment. By matching the selected individuals to 
data in the CSFII database, food consumption data for each of the 365 days are obtained. 
Using the FCID (Food Commodity Intake Database, USDA/ARS and EPA/HED), the 
daily eating event data are converted to 24-hour summaries of raw agricultural commod-
ity intakes (limiting risk assessments to periods for one day or more), both in amounts 
and preparation of the commodity (raw, peeled, cooked, juiced, etc).  
Data on pesticide residues in the raw agricultural commodities (RACs) must be provided 
by user. These may be single values such as tolerance data, small groups of field trial 
data, or large monitoring databases. 
Residue data are matched to the food intakes using additional (user supplied) information 
such as percentage of the crop treated, surrogate values for similar commodities, number 
of residue zeroes to be used, modification factors for prepared commodities. Actual expo-
sure is calculated by assigning residues from a distribution to all the foods consumed by a 
person on every day of the year and integrating this procedure over the selected popula-
tion. CARES produces three summary values for a simulated individual: maximum daily 
value, average daily exposure and the total exposure value for the 365-day period. 
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2. Residential exposure 
CARES uses exposure scenario definitions as defined in the US EPA SOPs. For the resi-
dential exposure estimation the program needs relations between: 
• ingredients and products  
• products and efficacy periods 
• products and exposure scenarios (from the SOPs), including user/non-user and 
professional vs. consumer use 
• scenario and seasonal use 
• scenario and day of the week use 
• products and re-entry periods 
• scenarios and co-occurrences of use 
• scenarios and annual numbers of use 
Furthermore, market share data of the product are needed. 
Based on the provided relations exposure events are allocated for a simulated person for 
the entire range of 365 days. This is done in steps: 
• the number of scenario events is randomly generated 
• these events are distributed randomly over the year 
• the number of products used per event is randomly generated 
• a product that is used is randomly picked per event  
 
The distribution of exposure is obtained by repeating the procedure for all individuals in 
the selection of the population. 
The program needs user input data (depending on the scenario) on available residues, 
degradation of the residue, dermal contact areas, use durations, flux rates, areas treated 
and transferable residues. 
The actual exposure estimation relies on the route specific unit exposures (such as milli-
grams exposure per amount active ingredient used) as derived in the PHED database. 
Parameters such as exposure probabilities are derived by CARES from the individual 
characteristics. 
 
3. Water exposure 
CARES evaluates tap water exposure by combining 365 daily water consumption values 
with daily water residue values provided by the user. The profile of residue data has to be 
spatially and temporally specific. Each individual in the CARES reference population is 
linked to a water consumption pattern based on individual characteristics such as age, 
gender, state of residence. 
CARES offers 4 options to characterize the water consumption of the people in the refer-
ence population: 
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• water consumption based on USDA/CSFII-data 
• a default of 2 liters per 70 kg body weight 
• EPA/WHO constants for water consumption 
• Age adjusted constant water consumption 
 
CARES does not include tap water exposure due to bathing and showering. 
 
Data needs 
CARES utilizes a large number of databases and default data, such as the CSFII database 
on dietary consumption, the Novigen Sciences Food Commodity Intake database, the 
1990 U.S. Census (PUMS dataset) and the PHED database. 
The user has to provide data on pesticide residues in food, transfer coefficients and active 
ingredient amounts for residential exposures, residues in ground or surface water, physi-
cal and chemical properties of the active ingredient and toxicity information. 
 
Aggregation framework 
CARES calculates aggregate and cumulative exposures for pesticides using a calendar-
based approach: aggregate doses are evaluated for an individual for each day in a year 
(extending from 1 January to 31 December). The program evaluates potential risks from 
dietary, drinking water and residential sources from oral, dermal and inhalation routes of 
exposure. Risks can be calculated deterministically or probabilistically using Monte Carlo 
techniques. CARES calculates doses and risks from acute (1-day), short term (2-30 days), 
intermediate term (1-3 months) and chronic (1 year) exposures, allowing for the calcula-
tion of moving averages. 
Exposure pathways include dietary exposure, exposure to pesticide residues in tap water, 
and residential exposure due to pesticide use in the home. 
Risks are expressed as percentile distributions of toxicologically equivalent doses, mar-
gins of exposures, or hazard indices (the ratio between actual dose and RfD). 
Doses are calculated route and source specifically for one individual on one day and 
combined to obtain an aggregate dose for the individual. A population distribution of the 
dose is constructed from the aggregate doses of a group of individuals in a specified 
population. 
Aggregate risk is characterized by the distribution in the population of a risk measure 
such as the MOE. 
For assessing the cumulative risk the joint probability of exposure to two or more chemi-
cals is determined.  
The resulting exposure is presented as a combined distribution of toxicologically equiva-
lent doses, hazard indices or margins of exposures. 
 
CARES constructs a reference population of 100.000 persons combining data of the 1990 
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US census (PUMS database) with the CSFII/FCID food intake databases and 
NHAPS/REJV databases on activity patterns by matching records with the same or simi-
lar attributes such as age, gender and ethnicity.  
For each modeled individual in this reference population (or a sub selection thereof) a 
365-day exposure profile is created, consisting of daily doses from exposure aggregated 
across all routes and pathways. 
 
Applicability to European situation 
CARES has intensive data requirements. The databases provided with the program are 
US specific databases. Many of these data may not represent situations at other geo-
graphical locations than the US very well. For any specific assessment at a non- US (e.g. 
European) location, it may be necessary to obtain similar data for the geographical region 
of interest. 
 
2.3.3   LifeLine 2.0 
General description 
The tool was developed by the LifeLine Group, Inc. 
LifeLine 2.0 implements an aggregate framework to assess the total human exposure to 
pesticides that are either released by agricultural or residential use. The program distin-
guishes three pathways: dietary intake of pesticide residues in food, exposure to pesticide 
residues in tap water via ingestion and bathing, and exposure due to residential use of 
pesticide products. It facilitates both deterministic screening level calculations and more 
detailed, probabilistic assessments. Exposure levels, carcinogenic and non-carcinogenic 
risks are assessed either for the total US population or for specified subpopulations. 
Health risks are reported as Margin of Exposure, Reference Dose or Fraction of Refer-
ence Dose. The program can also estimate cumulative exposures35. 
 
Exposure calculations 
1. Dietary exposure 
Dietary intake is estimated from pesticide residue data in the food stuff by selecting food 
consumption records from CSFII dietary surveys. Dietary records can be matched to 
demographic characteristics of the simulated individual such as age, sex, region or socio-
economic status. Residue data must be specified at commodity (raw ingredient) or food 
form levels. 
 
2. Residential exposure 
Residential exposures arise from the use of pesticides in and around the house. LifeLine 
determines pest pressures for the residence of the modeled individual using NHGPUS 
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data on (geographical related) pesticide use and additional residential factors (presence of 
lawn/fruit trees etc.). From pest pressures and labeling instructions, daily probabilities of 
home pesticide application are inferred. LifeLine 2 follows the residential pesticide expo-
sure scenarios as described in the EPA SOPs. The program distinguishes between handler 
(application) exposure and post-application exposure to residues.  
For the user exposure the program offers two approaches: 1) unit dermal and inhalation 
exposures are obtained from the PHED database as surrogate values, or 2) the user must 
specify exposure as percentages of the active ingredient that is applied. Using these unit 
exposure data, exposures are modeled using the dimensions of the modeled residence and 
application rates. 
The post-application exposure is determined from residues left behind in different media 
after application. These residues are estimated for different product types using the 
amount of active ingredient used and crude assumption with regard to the emission. The 
residue level is modeled as declining in the course of time based on a user specified de-
cline rate. Exposure is determined by deriving contact data with the contaminated me-
dium from time activity data (NHAPS survey).  
 
3. Tap water exposure 
Pesticide residues from agricultural runoff may disperse into surface and ground water, 
from where these residues may end up in drinking water sources and may lead to expo-
sures of persons drinking the water or bathing in it.  
The user of the program has to provide residue data for different types of drinking water 
sources. Dependency on census region, water source, season of the year and others can be 
included, if the data are available. 
Residue data are matched to residences based on census region, season, urban or rural 
setting, and the type of water supply, using the AHS database. 
In determining the inhalation dose of a person taking a shower in the bathroom, the air 
concentration in the bathroom is estimated based on the (seasonal) water concentration, 
the water throughput, the Henry-coefficient of the active ingredient, and the bathroom 
volume of the residence of the modeled person. 
The dermal dose due to contact with shower water is estimated from the estimated ex-
posed surface area of the skin, the estimated Kp of the skin, the concentration of active 
ingredient in tap water and the exposure duration. 
Oral exposure is calculated as the concentration of active ingredient in tap water times the 
amount of tap water consumed. 
 
Data needs 
LifeLine utilizes a number of US databases, such as the National Centre for Health Statis-
tics data on population characteristics (Natality database and National Health and Nutri-
tion Examination Survey), CSFII database on dietary consumption, NHAPS, NHGPUS 
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and AHS. 
The user has to provide data on pesticide residues in crops, agricultural commodities or 
food, drinking water supplies, physical and chemical properties of the active ingredient 
and toxicity information. 
 
Aggregating exposure 
In LifeLine, the exposure of a person is simulated for every day of his life, resulting in a 
day-by-day exposure profile for the modeled person. All the above mentioned pathways 
will contribute to this profile. The day-by-day exposures are evaluated and stored both 
per route and integrated over the routes. A population distribution of these profiles is 
generated by repeating the procedure for a reference population by performing Monte 
Carlo analysis. 
Within this modeling procedure the program: 
• assigns appropriate age dependent attributes to the modeled person at various life 
stages. 
• maintains autocorrelations (over time) between exposure factors such as body-
weight at different ages. 
• maintains correlations between various factors such as pesticide use with season, 
region of country, type of home, frequency of use and last time of use. 
• registers exposures arising from pesticide applications in the past. 
 
After the construction of the exposure profiles specific evaluations can be made such as: 
• exposure of subpopulations 
• the impact of frequency and duration of exposures, by calculating running aver-
ages over various time periods, ranging from days to years 
• the relative contributions of the different routes of exposure 
 
Applicability to European situation 
Assessments with the LifeLine software require a large amount of data. The databases 
provided with the program are US specific databases. Many of these data may not repre-
sent situations at other geographical locations than the US very well. For any specific as-
sessment at a non- US (e.g. European) location, it may be necessary to obtain similar data 
for the geographical region of interest. 
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3. Aggregate exposure to chemicals from consumer 
products 
 
 
One potentially important pathway of exposure of humans to chemicals is the exposure to 
chemicals released from consumer products. As a chemical may be contained in widely 
different types of products, it may not be appropriate to evaluate risks for each product 
containing the chemical separately. Rather, the total of the exposure arising from all the 
different products has to be determined.  
In this section we discuss how a determination of the exposure from different consumer 
products might be done. We will refer to this summation as aggregation, understanding 
that this is a narrower definition of the term than the one used in earlier sections of this 
report, since not all, but only a part of all possible pathways of exposure and sources is 
considered. Many of the considerations and methods discussed in chapter 1 apply here as 
well.  
In section 3.1 a conceptual procedure for the aggregation of consumer product exposures 
is given. In the field of consumer exposure assessment, monitoring data and other direct 
measurements of the exposure are rare. In practice, the assessor often has to revert to the 
use of modeling. In section 3.2 a list of available consumer exposure modeling tools is 
presented with a short description of their characteristics. Their possible utility in the ag-
gregate assessment of the exposure from consumer products is briefly discussed. 
Finally, in section 3.3 possible implementations of the conceptual procedure defined in 
section 3.1, for different applications in a risk assessment, are sketched and illustrated 
with a detailed example. 
 
3.1. Assessing aggregate exposure to consumer products 
 
In the assessment of the impact on the human health due to chemicals in consumer prod-
ucts, it is customary to take following steps: 
• determination of the scope and purpose of the assessment 
• establishment of the exposure scenario 
• assessment of the exposure based on the scenario 
• characterization of the expected health impacts 
 
When presenting the results of a risk assessment to the public or other stakeholders, the 
assessor will in addition have to discuss the accuracy and reliability of his assessment. 
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Uncertainty pertains to all the different parts and steps of an assessment36,37,38. A system-
atic treatment of uncertainty is to be an integrated part of any risk assessment. To limit 
the scope of this report we do not consider these aspects here, however. 
 
Scope and purpose of the assessment 
Exposure assessments are usually performed to protect public health, i.e. to protect a 
population of potentially exposed persons. The approach to estimate the exposure of this 
population may vary from one occasion to another.  
The scope and purpose of the assessment dictates what level of detail is required to meet 
the demands of the posed risk question. If an order-of-magnitude estimate is asked for 
(for example: an initial screening of the exposure of a population for potential risks or 
prioritizing of assessments for different chemicals), the population is often represented by 
a single, hypothetical, high-exposed person for which a deterministic exposure assess-
ment is done, using conservative values for exposure factors. It is assumed that the expo-
sure of this person represents a higher bound to the actual exposure in a population, so 
that, if for this hypothetical individual the exposure is below a certain safe level, there is 
no reason for concern relating to the exposure to this chemical. If, however the estimated 
exposure level lies above a level of concern, an additional, more sophisticated assessment 
of the exposure may be required. 
If on the other hand, a detailed assessment of the distribution of exposure in a population 
has to be established (for instance to identify the highest exposed subpopulation, or to 
quantify the distribution of expected effects within the population), different groups or 
individuals have to be identified in the population, for which exposure estimates have to 
be determined separately. This approach requires more detailed data on various parame-
ters (distributions of exposure parameters within a population, data distinguishing differ-
ent groups or individuals in the population such as age, sex, social status, region). 
The exposure is, as a rule, determined using probabilistic techniques, such as Monte 
Carlo simulation. 
These different levels of complexity are often combined in a tiered approach. The rela-
tively simple screening evaluations are performed first to assess whether a more detailed 
approach is needed, and if so, whether specific pathways or sub populations can be ne-
glected in a more elaborate assessment. 
If the screening level assessment is not conclusive, progressively more detailed and so-
phisticated evaluations have to be performed. 
 
Exposure scenario 
The actual assessment always starts with some sort of scenario definition: a conceptual 
description of the processes, assumptions and parameters that are thought to represent the 
exposure situation in so much detail as is adequate to answer questions posed by the risk 
assessment requirements. This scenario will direct how the evaluation will be performed 
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and what monitoring, data collection or modeling strategies will be used. The scenario 
description addresses questions regarding the required detail of the assessment. For in-
stance, the timescales of the exposure assessment should correspond to the toxicological 
endpoints that are of interest. The timescales on which the exposure is to be determined, 
on the other hand, determine the level of aggregation of a population or dis-aggregation 
into sub-populations, and the detail with which individual exposure events should be de-
scribed. 
The scenario will identify which pathways and routes of exposure are to be regarded and 
what the endpoints of the exposure assessment should be.  
For the case of the assessment of aggregate exposure to substances in consumer products, 
the scenario description will include a list of consumer products that contain the chemi-
cal(s) of interest. In addition, it will have to describe how exposure to each of these prod-
ucts may take place, that is, it will include sub-scenarios for the different products.  
In the construction of these sub scenarios it should be acknowledged that the exposure 
from a single product can occur in different ways and at different occasions. The expo-
sure may arise when a person uses the product himself, or it may occur when someone 
else is using the product and a person is just standing-by. Still differently, it may be that a 
person is exposed after the product has been used upon entry of the room where the prod-
uct was used. All of the relevant exposure events have to be identified and described. In 
addition, a strategy to add the exposures from these different events has to be adopted. As 
described in chapter 1, this addition should be done using a person oriented approach. 
Depending on the time resolution, this profile could consist for instance in a day-by-day 
listing of the exposure events that are likely to take place for the modeled person, or it 
could be a year averaged profile, consisting of summation of all the averaged doses for 
the different exposure events. The approach to follow in this aggregation step again is 
dictated by the demands posed by the scope and purpose of the risk assessment question. 
Exposure events from different products may overlap when products are used simultane-
ously or when the exposure to one product extends for some time its use, and may coin-
cide with the exposure to another product or a repeated use of the same product. The ex-
posures may in combination lead to an excess of a tolerable level, although the exposures 
from each product separately are below this level. So, in addition to exposure factors re-
lating to single product exposures, data on the temporal correlations and the autocorrela-
tions will have to be known (i.e. the probabilities that products will be used simultane-
ously, the average time between repeated uses of the product, etc). 
 
Assessment of the exposure 
The exposure scenario and its sub scenarios that describe the exposure profile, point out 
how the evaluation of the exposure should be done. This evaluation consists in the trans-
lation of the functional relationships determined in the scenario into mathematical equa-
tions, the selection or formulation of models describing the different exposure events, the 
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collection and description of data on the included products, relevant exposure factors, an-
thropometrics and other population characteristics, the design and implementation of 
monitoring studies etc. 
The collected data, models and directly measured exposure data are used to evaluate the 
different sub-scenarios that describe individual exposure events. These are subsequently 
integrated in a way that corresponds to the risk question. For instance, the day-by-day 
exposures in a population per route, or integrated across all routes, the distribution of the 
year averaged exposure over the population, or just the conservatively estimated higher 
bound of the exposure within the population etc. 
 
Risk evaluation 
Finally, the results of the exposure assessment are used to quantify the health impacts 
within the population. This can be as simple as a statement regarding the probability that 
a certain level of concern is exceeded in the population, but could also be a detailed quan-
tification of the number of people for whom the exposure exceeds this level of concern 
and the extent to which it does. Also various questions with regard to the distribution of 
exposures and risks within the population should be answered in this phase. Such as the 
identification of dominant routes of exposure, the determination of the products that drive 
the exposure to the chemical, the evaluation of possible risk reduction measures. 
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Figure 2 Conceptual model of the aggregation of the risk assessment of chemicals from 
multiple consumer products. Exposure profiles are constructed for individuals or groups 
of individuals in a population. These consist of the combination of exposure scenarios 
describing different ways in which a person may be exposed to chemicals in consumer 
products. These individual exposure profiles are integrated over the entire population to 
obtain measures of the exposure of this population. These exposure measures may subse-
quently be used to characterize the risk or health effects in the population. 
 Population   Substance 
Individual 2 
Individual 1 
Individual N1
Products 
Product 2 
Product 1 
Product N5 
Scenarios 
Scenario N3 
Scenario 2 
Scenario 1 
Profile 1 
Profile 2 
Profile N2 
Exposure 
Integrated over 
population 
• daily dose high-
est exposed 
group 
• distribution 
chronic dose 
• distribution high-
est exposure 
event 
• etc…
Toxicological profile 
 
• ADI 
• Dose-effect relation 
• NOAEL 
• etc.. 
Risk characterization 
• MOE highest exposed group 
• distribution MOE 
• etc… 
Page 48 of 71  Report 630700001 
 
3.2  Consumer exposure modeling tools 
 
There is a number of more specialized computer tools that implement models to estimate 
the exposure of humans to chemicals in consumer products. The level of complexity and 
the area of applicability vary among the tools. Some of these programs only cover a lim-
ited group of products or a limited number of exposure routes.  
Below, a short description of the capabilities of the different programs is given. It is dis-
cussed to what extend, if at all, each of the tools could be used in aggregate exposure as-
sessments. 
The computer tools discussed in this section are:  
• ConsExpo 
• MCCEM 
• PROMISE 
 
ConsExpo 
ConsExpo has been developed at the Dutch National Institute for Public Health and the 
Environment (RIVM)39,40. The program implements a suite of consumer exposure mod-
els. The complexity of these models ranges from screening level to more advanced, de-
tailed mechanistic models. The tool covers the oral, inhalation and dermal routes of expo-
sure. Using simple absorption models the exposures can be integrated across the different 
routes to yield total internal doses.  
Typical pathways of exposure which can be studied with the models include:  
• aerosol exposure due to the use of spray cans for user and bystander  
• exposure to vapours from products (i.e. paints, cleaning products) both during ap-
plication and post-application. 
• dermal exposure due to transfer from contaminated surfaces to the skin (i.e. pesti-
cides, cleaning products) 
• migration of chemical substances from clothing to the skin (i.e. dyes from cloth-
ing) 
• diffusion of a chemical from a product to the skin (i.e. cosmetic cream) 
• ingestion of substances migrating from a mouthed object to the saliva (i.e. teeth-
ing rings) 
 
Chronic (yearly averaged dose per day) and acute (total dose per event or per day of ex-
posure) exposures are evaluated. Risk evaluation is not a part of the program. 
The program includes a database with default data and recommended exposure scenarios 
for different consumer product groups. At present data on cosmetics, pest control prod-
ucts, cleaning products and disinfectants are included. 
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Aggregation 
Evaluations in ConsExpo are done for one product and one chemical at a time. 
In ConsExpo exposure events are treated separately. The exposure is calculated for a sin-
gle exposure event. Inference of chronic doses is done by multiplication with the expo-
sure frequency data. Temporal overlap between exposure events is not considered. 
The program includes limited tools for performing distributional calculations. Only sim-
ple, one-dimensional Monte Carlo analyses are supported and correlations between model 
parameters are not regarded. This makes the feature more suitable for sensitivity calcula-
tions than for population assessments. 
Hence the model as such does not facilitate aggregate exposure assessments.  
 
Multi-Chamber Concentration and Exposure Model (MCCEM)  
The program is developed by Versar Inc. on behalf of the US EPA/OPPT to aid in the 
evaluation of new and existing chemicals41. The tool considers inhalation exposure only. 
It models time varying indoor air concentrations and inhalation exposures in different 
chambers of a residence, including the effects of emission sources, sinks, air exchange 
between different chambers (zones) in the residence. 
The possible sources of exposure include consumer products, building materials and in-
door furnishings. These sources must be characterized by the user as time-dependent 
emission rates (as constant, single exponential incremental and data entry).  
Up to four different zones within a residence can be simulated. The software maintains a 
library of residences in different US geographical areas with data on zone volumes and 
interzonal flows and whole house exchange rates42. The user can use this library or spec-
ify his own values.  
The time scales considered range from acute (peak concentrations and single day doses) 
to chronic (lifetime average daily doses). 
The program offers a limited possibility to do distributional calculations: only for a num-
ber of parameters such as infiltration rates, emission rates, and sink rates. 
 
Aggregation 
The usability of the program for doing aggregate exposure estimates seems limited. In the 
first place, it considers only inhalation exposure, which restricts the applicability to 
sources and products for which this route of exposure is the dominant one. Secondly, the 
program combines the exposure of different sources in one event, but has no option to 
integrate over multiple exposure events. Such an integration (which is essential in an ag-
gregate assessment where exposure could arise from different sources at different points 
in time) should be done outside the program by the user. Furthermore, the program does 
not support population based assessments. Its applicability is therefore restrained to the 
screening type of assessments. 
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PROMISE©  
PROMISE© is a software tool developed by Silken, Inc. for the Solvents Council of the 
American Chemistry Council to assist in the exposure assessment of industrial chemi-
cals43. PROMISE© is primarily designed for estimating single exposure events in occupa-
tional settings and in certain consumer-type applications. The program is best adapted to 
chemicals that have some volatility and exist either in the pure form or in a formulation. 
Multiple routes of exposure (inhalation, ingestion, and skin absorption) may be assessed. 
With the program, event exposures are estimated for a scenario. It is assumed that the ex-
posure is the same for all the exposure events that may occur in the course of time. Year 
averaged daily doses are derived by multiplication with the use frequency (per day).  
PROMISE© has a probabilistic ‘front-end’ that allows the use of input variable ranges 
and distributions rather than single value point estimates in the calculation of dose. The 
user has a choice of up to 15 different types of distributions. PROMISE© allows the dis-
tribution of dose (milligrams of chemical per kilogram of body weight per day) from the 
defined scenario to be evaluated, visualized, analyzed, documented, saved and compared 
to alternative scenarios, alternative exposure and uptake models, and different similar 
scenarios using alternative input values.  
 
Aggregation 
PROMISE© was not designed for use in cumulative or aggregate exposure assessments. 
Variation of the exposure between exposure events can not be modeled. Also, exposures 
from different sources can not be combined within the program. 
 
Conclusion 
As can be concluded from the reviews above, none of the programs developed for the as-
sessment of consumer exposure supports aggregation of the exposure from different con-
sumer products. The ConsExpo and PROMISE programs (or more likely, the exposure 
algorithms they implement) can however be used in a higher level aggregation frame-
work to evaluate the separate exposure scenarios. Proper addition of these scenarios, 
however would have to be done in a separate routine, to be implemented in the embed-
ding framework. As the MCCEM model only considers inhalation exposures its applica-
bility in a general aggregation framework seems limited. 
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3.3 Possible implementation of aggregate human exposure as-
sessment to chemicals in consumer products  
 
As described in section 3.1, the manner in which aggregate exposure is assessed depends 
on the scope and the purpose of the assessment as defined by the risk management ques-
tion. In this section we propose in some detail approaches for three different types of risk 
assessments: 
• a screening level assessment (tier 1) 
• a more detailed population assessment in which only chronic exposure (year aver-
aged) endpoints are to be considered (tier 2) 
• a detailed assessment of the population exposure on a day-by-day basis, to assess, 
among other things, the acute (daily averaged) exposures (tier 3) 
 
These three types of assessments typically constitute different steps in a tiered assess-
ment, where a non-conclusive outcome of a lower tier assessment calls for a more refined 
estimation of the exposure*.  
For each approach data requirements are specified and an outline of a general framework 
that could be used in the evaluation is sketched. As direct measurement of exposure data 
for chemicals from consumer products is rare and costly, the assessment of the event ex-
posures is assumed to be done by modeling. 
 
All the approaches described below share a number of common steps. First of all, in the 
specification of the scenario the products that contain the chemical of interest will have to 
be listed, together with, at a minimum, data on the amount of chemical that these prod-
ucts contain, a basic description of the use pattern of the products such as its use fre-
quency and the amount of product used per event. Based on the expected use of these 
products, pathways of exposure have to be determined and in relation to these, the sub-
populations that will be exposed via these pathways. From these, exposure profiles will 
be constructed, combining the exposures from different exposure events for the different 
products. In assessing the actual exposure for the different events, these different expo-
sure events could, in principle, be determined by direct measurements, but in the absence 
                                            
* The assessment type that is defined here as the first tier, is in practice sometimes preceded by a yet cruder 
estimation, which could be referred to as a zeroth tier: an order-of-magnitude estimation based on an esti-
mate of the total volume of the chemical available for potential exposure (derived from estimates of the 
number of products on the market and the amount of chemical each product contains) and the size of the 
exposed population. In this approach, no specific exposure scenario is assumed, only the potential uptake of 
the chemical in the population. Such an  approach is principally used to prioritize between risk assessments 
of different substances. 
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of representative monitoring data these exposures may be modeled (or the computer tools 
described in section 3.2 could be used). Depending on the specifics of the approach, these 
event exposures have to be summed into an aggregate assessment. 
Summarizing, the basic data needs for all three approaches are:  
• listing of the products containing the chemical 
• the amount of the chemical that is contained in the product 
• use data on the product: a use description, amounts to be used, use frequencies 
• basic population data: body weight 
 
Tier 1  
The exposure for a subject is estimated using conservative assumptions on the different 
exposure factors. The assumption is that when the exposure for this person is below a cer-
tain level of concern, this is a reasonable guarantee that the exposure levels for most of 
the population are below this level and hence, there is no reason for concern regarding the 
exposure from this substance. This is a cheap and quick approach that is mostly taken as a 
first tier in a more complete risk assessment, screening whether a more elaborate ap-
proach should be enforced or whether this is not necessary.  
In using this approach for the aggregate exposure estimation to chemicals in consumer 
products there is a number of specific considerations that apply. Although the approach 
permits and demands the use of conservative assumptions, consistency of the exposure 
profile should be maintained. This means that not all possible exposure events will apply 
to the person that is to represent our (sub) population. As a consequence it may be neces-
sary in this type of assessment to repeat the procedure for different persons, representing 
different groups in the population. It may, for example, be necessary to estimate the ex-
posure for users of different (mutually exclusive) products and for children that are indi-
rectly exposed, but possibly more sensitive to the effects of the substance. 
This type of screening assessment needs to construct a representative person for each 
group within the population. A conservative estimate of the exposure will be made for 
each group, assuming high exposure values for the different exposure factors (high per-
centiles of distributions if these are available). For each of the exposure pathways, a sin-
gle exposure event is calculated (variation in the exposure between different events is not 
included). The group for which the impact of the exposure is expected to be highest de-
termines the conclusions regarding the safety of the exposure. Using this approach, there 
is no information on the variation of the exposure within the population, nor is there any 
indication of how conservative the estimate is. It may be far beyond any level of exposure 
actually encountered in the population, or it may be just at a high percentile of the ‘true’ 
distribution of the exposure in the population, not protecting a group of highly exposed 
individuals. 
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Tier 2  
A more detailed population assessment in which only chronic exposure (year averaged) 
endpoints are to be considered. 
In this case, sub populations would not be represented by a single, hypothetical individ-
ual, but one rather aims at characterizing the entire population, specifying distributions of 
exposure determinants within the population, and then modeling individuals in the popu-
lation from realistic population data and constructing exposure profiles for these persons. 
This procedure is repeated for a large number of similarly modeled persons, so that a rep-
resentative modeled population is obtained. Since one is regarding long time averages 
here, details of the temporal correlations between exposure events are neglected, expo-
sures can be determined using estimates of the separate exposure events multiplied by the 
exposure frequencies and add the average exposures from the different products.  
Additional data that are needed to follow such a scheme include:  
• distributional information on product use: 
o variation within the population of the amounts used per event 
o variation within the population of the number of products used  
o variation within the population in use frequencies  
o (anti-)correlations between the use of different products (i.e. some prod-
ucts are more often used together or their uses are mutually exclusive) 
• distributional information on anthropometric data  
• distributional information on exposure factors 
This approach yields a distribution of the year average exposure to the combined expo-
sures of several products. With this type of assessment one obtains an insight in the varia-
tion of the exposure within the population making it possible to identify high exposed 
sub-populations and quantifying the number of people that experience exposure levels 
higher than an acceptable level and the amount by which their exposure exceeds this 
level. 
In this approach there still remain different options as to what level of detail one wants to 
describe the exposures, and hence, what data to include and for which of these data one 
wants to determine the distributions within the population and for which one would use 
average estimates or other suitable point values. The choice between these different levels 
is on one hand dictated by the risk question and on the other hand by a limitation of re-
sources. Useful data on exposure factors is sparse in the field of consumer exposure esti-
mation. Filling these data gaps for a specific assessment will be costly and time consum-
ing. Including more detail into an assessment will as a rule require more input data. In the 
absence of these, the introduction of more detail into the assessment comes at the cost of 
a higher degree of uncertainty in the outcome.  
In this approach a variation in the exposure arising in the different exposure events 
should be included. This variation will be the consequence of the variation in the various 
exposure factors. To keep the assessment as simple as possible, a good starting point 
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seems to be the minimal data set specified earlier. The only variations in exposure taken 
into account would then be due to the variations in use frequency, used amounts and 
number of products used. Each exposure event could be characterized by an exposure per 
unit of product used (i.e. an exposure per kg product or per liter product). Unit exposures 
could be estimated using models (such as, for instance but not necessarily, implemented 
by computer tools). The exposure profile is constructed on a person-to-person basis from 
the product use data. The exposure events can in this (long term average) case be evalu-
ated as an average per event per route (lifelong or yearly, or whatever the required time-
scale is). This is, as was explained in chapter 1, because only chronic exposures are de-
termined and whenever the averaging time is much longer than the typical exposure 
times, the co-variances between the different events averages out and averaging can be 
done per pathway irrespective of the other pathways. In the calculation of the average ex-
posure per event, the information of the use frequencies should be used. From the differ-
ent (time averaged) exposure profiles, aggregation is done, first per route (yielding a total 
average exposure per route) and is subsequently integrated over the different routes to 
obtain a total average systemic or potential exposure. 
 
Tier 3  
In the last and most detailed tier, also acute toxicity endpoints are considered in addition 
to the chronic toxicity. The timescale on which exposure assessment will have to be per-
formed should correspond to that on which acute effects are expected. If this timescale is 
one day, for instance, exposure profiles have to be constructed on a day-to-day basis. In 
this case, additional data is required on temporal correlations between different exposure 
events. In the construction of daily exposure profiles, the probabilities of simultaneous 
exposure to two or more products on the same day should be accounted for. Also, it may 
be necessary to consider the fact that exposure after use of a product may last for longer 
than a day. So the history of exposure events should be explicitly regarded.  
The sort of data that would be needed (additionally) to complete an assessment in this tier 
would include: 
• the probabilities that products will be used simultaneously 
• the time profile of the individual exposure events  
For the entire exposure duration (which may vary from case to case and could be one 
year or a lifetime, for example) daily (or another acute timescale) exposure profiles must 
be constructed, again on a person-to-person basis. From the resulting exposure diary, 
longer time averages as well as maximal acute exposures (e.g. highest days of exposure) 
could be derived for the population under study. Aggregation is essentially done in the 
same way as in the second tier. First, the daily exposures are summed per route for one 
individual, and subsequently integrated over the different routes (using an appropriate 
risk metric) and, if necessary, averaged over longer exposure durations. 
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3.3.1 Example: exposure to a substance contained in multiple cleaning 
products 
As an example of the techniques described above we show in this section how the aggre-
gate exposure to a hypothetical substance in multiple cleaning products could be as-
sessed. We implement the three different procedures proposed and illustrate how the data 
demands increase as the required level of detail increases. 
We base the discussion on a research by Weegels44, which provides preliminary data on 
the use of different cleaning products. In this study, data were collected on the contact of 
consumers with different consumer products (in particular household products). These 
data included use durations, frequencies and amounts used. It is shown how these data 
could be used in a progressively more detailed exposure assessment. 
The substance of concern is supposed to be contained in a dishwasher product, an all-
purpose cleaner and a toilet cleaner. The nature and function of the substance are not 
specified here, but it could for example be a surfactant, a perfume or a dye. 
 
Scenario and exposure event models 
To begin the specification of the exposure scenario, the products that contain the chemi-
cal have to be characterized in terms of the amount of the substance they contain (i.e. as a 
concentration or fraction of the weight). 
Next, the pathways and routes of exposure should be identified. In this case we assume 
the following sub scenarios: 
For the (liquid) dish washer, exposure takes place: 
1. when preparing the suds (dermal exposure due to spillage) 
2. when washing the dish (dermal and inhalation exposure) 
3. due to residues of the substance on the dish (oral exposure via food intake from 
the dinnerware) 
The scenarios 1 and 2 apply only to the people using the product. Scenario 3) applies also 
to non-users. Scenario 1) and the dermal contact of scenario 2) apply to users of the prod-
uct only. Inhalation exposure during scenario 2) also applies to non-users of the product 
who are in the same room where the product is used. 
For the all-purpose cleaner we assume exposure: 
4. when preparing the suds (dermal exposure due to spillage) 
5. during cleaning (inhalation exposure due to evaporation, dermal exposure due to 
rinsing of cloth in the suds and wiping with a cloth) 
Finally, we assume the exposure to the toilet cleaner to take place during the use of the 
product (cleaning) only. Exposure is via inhalation of evaporating substance as well as by 
dermal contact.  
For the sub scenarios described above, the exposures during a single event must be as-
sessed as a function of exposure factors that may vary within a population (such as the 
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amounts used, for example). To evaluate these sub scenarios different options are avail-
able. Exposures could be estimated from monitored concentrations or can be modeled 
using tools such as ConsExpo or Promise. In this case we choose to describe the event 
exposures using a set of simple model equations. These equations and tables, with the 
input data used, are described in Appendix A. 
 
Exposure evaluation 
Tier 1 
Data on exposure factors are collected from different sources. Data on the use patterns of 
the above products are derived from the study by Weegels on the contact of consumers 
with household products. This study was performed in small populations (the number of 
persons is ranging from 9 to 45) which limits the representativeness for larger popula-
tions. The values for the different exposure factors should therefore mostly be regarded as 
illustrative for the procedure.  
Anthropometric data such as body weights and surface areas of body parts are derived 
from the RIVM ConsExpo general fact sheet45.  
 
In the first tier we make an-order-of-magnitude estimate of the exposure of the highest 
exposed group within the population. We identify two possible groups of exposed per-
sons: 1) the (adult) users the product and 2) children that are indirectly exposed. The ab-
solute amount of chemical to which group 1) is exposed will be much higher than that of 
the second group, in terms of the systemic dose, which is expressed as an uptake per unit 
of body weight, the second group may prove to be the most important.  
For each group we choose representative, but conservative point values for the different 
exposure factors. What we are aiming at is an estimate of a realistic upper bound of the 
exposure in the population. This means that we will chose values for all parameters that 
are in the high-exposure range, but preferably not beyond the realistic boundaries of the 
parameter. When detailed data are present, such as for body weights, conservative, but 
not overly conservative values are adopted. In the case of more limited datasets such as 
the consumer contact data from the Weegels study, the most unfavorable values are cho-
sen (maximum values encountered in the experiments). 
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Using the values given in Appendix A, the total exposures for the two different groups 
are calculated as: 
 
adult user (chronic exposures mg/kg/day) 
 dish washer all-purpose cleaner toilet 
cleaner 
summed over 
products 
inhalation 3.6 0.3 0.5 4.4 
dermal 16.3 0 0 16.3 
oral 1.1E-7 0 0 1.1 E-7 
summed over 
routes 
20 0.3 0.5 21 
indirectly exposed child (chronic exposures mg/kg/day) 
     
inhalation 0 5.75E-02 0 5.75E-02 
dermal n/a n/a n/a n/a 
oral 6.18E-7 0 0 6.18E-7 
total 6.18E-7 5.75E-02 0 5.75E-02 
 
This first tier estimate serves different purposes. First of all, it gives some crude upper 
bound of the exposures to be expected from the chemical. Second, if the MOE or other 
risk measure that is calculated from these exposures is not acceptable and a more detailed 
assessment is appropriate, the screening of the exposures for different sources, via the 
different routes and pathways indicates which of the sources, routes or pathways can pos-
sibly be ignored in the more detailed assessment to save resources, as their contribution to 
the overall exposure is expected to be negligible. In this case, when advancing to a higher 
tier assessment, we might choose to neglect the contributions of the oral route. Similarly, 
it is seen from this crude estimate that the dish washer is the most important source of the 
chemical exposure of adult users. Refinement of the assessment in a more advanced tier 
for this source should be a priority. 
For the sake of the example however, we include all the sources and routes in the elabora-
tion of the second tier assessment below. 
 
Tier 2 
In the next step, we refine the procedure above by including information on the variation 
in the values for the different exposure factors. Using distributions of values we calculate 
the distribution of exposure within the population. To properly aggregate the exposure 
arising from different products, we should pay attention to the following points:  
• personal consistency should be maintained in the aggregation. This means that for 
every simulated use of the product by a person, all the different sub scenarios de-
scribing the exposure from this product should be evaluated together for this per-
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son (i.e. in their evaluation the same data describing the person should be used). 
This is effectively achieved, by first assigning a use frequency and body weight to 
a person and using the numerical values of these parameters in the evaluation of 
all the sub scenarios. 
• correlations between data describing the exposed person and the exposure scenar-
ios that apply to this person should be taken into account. We choose in the sce-
nario description to distinguish between two groups in the population with en-
tirely different exposure profiles: adult users and children that are exposed indi-
rectly. There is obviously a strong correlation between data such as body weight 
and the exposure scenarios that apply to the simulated individual. This correlation 
was addressed by splitting distribution describing the body weight into two 
classes: body weights < 40 and body weights > 40. The first class is supposed to 
describe the children, the second group is the group of adult users. Note that this 
is a somewhat crude solution to the problem. A more refined procedure could also 
include exposure profiles of adults who are indirectly exposed during some events 
and exposed while using the product in other instances. 
 
Possible correlations between the different exposure factors (such as use frequency and 
amount used) are neglected in this assessment. Whenever such information is available, it 
should be included, however. 
Using this approach, insight is gained in the distribution of exposure within the popula-
tion. Rather than being able to identify only the highest exposed group and obtaining a 
reasonable higher bound of the exposure of this group, this procedure could estimate for 
instance the number of people within a population with exposures exceeding an estab-
lished safe level and the amount by which they do. 
This approach can however not give estimates of the acute exposures. The exposures are 
averaged over the time span of one year, and data on more detailed timescales can only 
be obtained when more detailed data on the temporal correlations of the different expo-
sure events is known. 
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Figure 4 Estimated total chronic dose of the exposed population of children  
(note: exposures in µg/kg/day) 
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Figure 3 Estimated total chronic dose of the exposed adult population  
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In increasing the level of detail of the assessment one acquires a more refined insight in 
the exposure of the population. In particular, an estimate of the distribution of the expo-
sure in the population under study is made. Comparing this with the deterministic calcu-
lations of tier 1, it is observed that the latter largely over-predict the exposure levels in the 
population as assessed in tier 2. As for the estimation of the relative importance of the 
different routes and pathways: these numbers change somewhat in going from the first to 
the second tier, but remain in the same order of magnitude. 
 
 
 
Relative contributions per route (distribution)
inhalation
dermal
oral
Relative contributions per route (point)
inhalation
dermal
oral
Figure 6 Relative contributions to the total exposure of the different exposure routes in the point 
calculation vs. probabilitstic calculation (adult population) 
 
Relative  contribution sources 
(dis tribution)
dish w asher
all-purpose
cleaner
toilet cleaner
Relative  contribution sources (point 
calculation)
dish w asher
all-purpose
cleaner
toilet cleaner
Figure 5 Relative contributions to the total exposure of the different products in the point calcu-
lation vs. probabilistic calculation (adult population) 
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To conclude this example, we describe the procedure that could be followed to arrive at 
an estimate on a more detailed timescale.  
 
Tier 3 
For this detailed approach, most of the relevant data is missing. It should be collected if 
such an assessment were needed. In the absence of these data and in view of the some-
what advanced complexity of the calculations, these are not performed here and only an 
outline of the procedure that could be followed is given. 
The customary approach is to construct an exposure profile with a time resolution of the 
required timescales. That is, if the required time resolution is one day, a daily exposure 
profile is to be constructed. For every day of the total exposure duration of a person 
(which could be a year, or a lifelong exposure depending on the circumstances) one has 
to determine which exposure events are likely to occur. This is normally done probabilis-
tically: based on data on the use frequency of the product and the history of the exposure 
(the number of exposures that has already occurred) a probability that exposure to this 
product will take place on the considered day is determined. Using this probability, one 
decides at random whether the exposure event will take place this day or not. This proce-
dure is repeated for all the products for the considered day. Subsequently, this procedure 
is repeated for the next day and the days thereafter, until the temporal exposure profile for 
the whole exposure period is determined. Then, the next person from the population is 
taken and the exposure profile for this person is determined in the same fashion. Finally, 
one arrives at a population of simulated individuals for which day-by-day exposure pro-
files are determined. 
In the construction of the daily exposure profiles data on (auto-) correlations between ex-
posure events should be considered if available. If, for instance a product is used only 
once a week, the probability of reuse of this product on the day after a day the product 
has been used should be set to zero. On the other hand, if the exposure to the substance 
stretches over a period for longer than a day (for instance due to the fact that the sub-
stance may still be evaporating into the air on the next days), this should be accounted for 
in the exposure profile on the day after the product was used. Similarly, if two different 
products have an increased or decreased probability to be used on the same day, this 
should be accounted for in the construction of the daily exposure profile. 
In our example, we would start with selecting a person from our defined population. As 
we distinguish in our exposure sub scenarios between children and adults, who are fun-
damentally differently exposed, we should first decide to which group our selected indi-
vidual belongs. This could be based on age or body weight for instance (note that a finer 
distinction could be made at this point, if desired. One could, for example, differentiate 
based on gender, social status, geographical location if such a distinction is expected to 
be relevant and this type of data on the population is available). Next, suppose we assess 
the yearly exposure to the substance. We would construct a profile consisting of  
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365 days. Starting at day 1 (1st of January), we would determine the probability of an ex-
posure to dish washer based on the use frequency of dish washer for this person, than de-
termine at random whether exposure to the dish washer takes place or not, and similarly 
for the all-purpose cleaner and the toilet cleaner. Next, we would move on to the second 
day (2nd of January) and repeat the procedure. In this fashion we arrive at a day by day 
exposure profile for a year for this person. From this profile, the daily exposure can be 
assessed in the same fashion described earlier, using values for the exposure factors that 
are drawn at random from the distributions of these parameters (amount of product used, 
exposure duration etc). This results in a day by day exposure estimation for this person. 
Repeating this for a large number of individuals results in a distribution of day by day 
exposure estimations. From this, not only distributions of year averaged exposures follow 
(which should match the results of the second tier approach), but also estimates of the 
distribution of the exposure on a single day (acute exposures) within a population. 
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4 Conclusions 
 
 
In this report we explored various tools and methods that can be used to assess the aggre-
gate human exposure to chemicals. Several existing computer tools that in one way or 
another consider exposure from different sources and along different pathways were de-
scribed. Especially their applicability to assess the aggregate exposure from chemicals in 
multiple consumer products was discussed. From the discussions in this report we draw 
the following conclusions: 
• The level of detail, with which aggregation is done, should be dictated by the 
scope and purpose of the assessment. Demands for a first tier, screening type of 
assessment on the required level of detail are much lower than those of an as-
sessment that has to give a realistic quantification of the variation of the exposure 
in a population.  
• Whatever the scope the assessment, the aggregation should be based on a person 
oriented approach: exposure profiles should be constructed for a single person, 
(may this person  represent the entire population or be a realistic model of a per-
son in the population) as this is the only way to ensure the consistency of expo-
sure profile in the sense that no unrealistic or unrepresentative combinations of 
exposure are added in the aggregation. 
• The only area in which aggregation techniques are fully implemented and made 
use of, is the field of exposure assessment to pesticides. The Calendex, CARES 
and LifeLine software programs enable the assessor to estimate exposures arising 
from different sources, such as tap water, food residues and household products to 
be aggregated in a consistent manner. Tools developed in other fields, in particu-
lar the assessment of human exposure to chemicals released as waste into the en-
vironment, generally do consider different pathways of exposure and sometimes 
allow for the aggregation (addition) of the exposures along these pathways, but do 
so in a crude manner, not enforcing the consistency and representativeness of the 
constructed exposure profiles. The results obtained by these methods should as a 
rule only be used as screening of upper boundaries or average values of the popu-
lation exposure (depending on the choices of input parameters, e.g. probable or 
conservative values). 
• There is a number of specialized software tools available for the assessment of 
consumer exposures, but none of these implements or facilitates doing aggregate 
assessment.  
• A lot of chemicals are present in a wide variety of consumer products At present 
risk assessment generally is performed on a product basis. Aggregate exposure to 
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chemicals in multiple consumer products is currently hardly considered but 
should be taken into account to get insight whether actual risk is .A tool to per-
form aggregate exposure to consumer products needs to be developed. 
• The present report provides a basis for the development of such a tool. 
Report 630700001  Page 65 of 71 
  
 References 
 
 
1 WHO - IPCS Risk Assessment Terminology part 2: IPCS Glossary of Key Exposure 
Assessment Terminology, 2004. 
2 www.epa.gov/oppfead1/fqpa/ 
3 BSEF. 2001. Major Brominated Flame Retardants Volume Estimates. Total Market 
Demand by Region in 2001. Brussels: Bromine Science and Environmental Forum. 
Available: http://www.bsef-site.com/docs/ BFR_vols_2001.doc  
4 Schettler T., Human exposure to phthalates via consumer products. Int. J. Androl. 2006 
Feb;29(1):134-9 
5 Wallace L., A decade of studies of human exposure: what have we learned? Risk Anal. 
1993 Apr;13(2):135-9 
6 Fryer M.E., et al. 2004. Evaluation of currently used exposure models to define a human 
exposure model for use in chemical risk assessment in the UK. Imperial College Report 
7 cem.jrc.it/cemdb/ 
8 Huijbregts M.A., et al. comparison between the multimedia fate and exposure models 
CalTOX and uniform system for evaluation of substances adapted for life-cycle assess-
ment based on the population intake fraction of toxic pollutants. Environ Toxicol Chem. 
2005 Feb;24(2):486-93A 
9 http://www.epa.gov/oppt/exposure/docs/opptexpo.htm 
10 RIP3.2-1 CSA Scoping Final Report 28072005 
11 US EPA Environmental Protection Agency Office of Pesticide Programs General Prin-
ciples For Performing Aggregate Exposure and Risk Assessments (2001) 
12 Brown, D., et al.. 1997. Dioxin and Dioxin-Like Compounds in Soil, Part 1, ATSDR 
Interim Policy Guideline. Toxicology and Industrial Health, 13:759-768 
13 NCEA. 1996. Guidance on Health Risk Assessment of Chemical Mixtures, National 
Center for Environmental Assessment, NCEA-C-0148 
14 http://eetd.lbl.gov/iep/era/caltox/ 
15 Van den Berg, R. Human exposure to soil contamination: a qualitative and quantitative 
analysis towards proposals for human toxicological intervention values (partly revised 
edition). RIVM Report 725201011 (1995) 
16 http://www.epa.gov/opptintr/exposure/docs/efast.htm 
17 http://www.rivm.nl/rvs/overig/risico/methoden/EUSES.jsp 
18 Lijzen J.P.A. and Rikken M.G.J., European Union System for the Evaluation of Sub-
stances 2.0 (EUSES 2.0); background report. RIVM report 601900005 
19 http://ecb.jrc.it/existing-chemicals/ 
20 http://www.census.gov  
21 US EPA 1997a ‘Standard Operating Procedures (SOPs) for Residential Exposure As-
sessments’ 
22 http://www.epa.gov/scipoly/sap/1997/ 
23 Klepeis N.E., The National Human Activity Pattern Survey (NHAPS) A Resource for     
Assessing Exposure to Environmental Exposures. Lawrence Berkley National Laboratory 
Report LBNL-47713 
Page 66 of 71  Report 630700001 
 
                                                                                                                                  
24 Klepeis N.E. and Nelson W.C., The National Human Activity Pattern Survey 
(NHAPS): a resource for assessing exposure to environmental pollutants. J Expos Anal 
Environ Epidemol volume 11 (2001) 3, 231-251 
25 US Census. American Housing Survey for the United States: 2003 
26 http://www.census.gov/hhes/www/housing/ahs/nationaldata.html 
27 Rizek R.L. and Pao E.M.. Dietary intake methodology I. USDA surveys and supporting 
research. J Nutr. 1990;120: Suppl 11:1525–9.  
28 What we eat in America 1994–1996: interviewer manual for the Continuing Survey of 
Food Intake by Individuals 1994–1996 and the Diet and Health Knowledge Survey 1994–
1996. Rockville, MD: Westat, 1993. 
29 PHED: The Pesticide Handler Exposure Database, Reference Manual, Version 1.1, 
February 1995 
30 The Pesticide Handler Exposure Database (PHED), Evaluation Guidance, Version 1.1, 
March 1995 
31 http://www.epa.gov/pesticides/science/models_db.htm 
32 http://www.exponent.com/practices/foodchemical/calendex.html 
33 CARES User Guide (http://cares.ilsi.org/CaresGuides.htm) 
34 CARES Technical Manual (http://cares.ilsi.org/CaresGuides.htm) 
35 LifeLine User’s manual. http://www.thelifelinegroup.org/lifeline/docs.htm 
36 Morgan M.G. and Henrion M. (1990)  Uncertainty: A Guide to Dealing with Uncer-
tainty in Quantitative Risk and Policy Analysis,  New York:  Cambridge University 
Press. 
37 US EPA 2004. Examination of EPA Risk Assessment Principles and Practices : Staff 
Paper Prepared for the U.S. Environmental Protection Agency by Members of the Risk 
Assessment Task Force. EPA 100/B-04-001 
38 van Asselt M.B.A., et al. 2001, Uncertainty & RIVM’s Environmental Outlooks. 
RIVM Report 550002001 
39 Delmaar, J.E., M.V.D.Z. Park, J.G.M. van Engelen, 2005 ConsExpo 4.0, Consumer 
Exposure and Uptake Models. Program Manuel. Bilthoven, The Netherlands: National 
Institute for Public Health and the Environment (RIVM). Report no. 320104004 
40 www.consexpo.nl 
41 http://www.epa.gov/oppt/exposure/docs/mccem.htm 
42 Versar, Inc.,1990. Database of Per fluorocarbon Tracer (PFT) Ventilation Measure-
ments, final report for USEPA Office of Toxic Substances, Versar, Inc. 
43 http://www.americansolventscouncil.org/resources/promise.asp 
44 Weegels M.E.and van Veen M.P. Variation of consumer contact with household prod-
ucts: a preliminary investigation. (Risk Anal. 2001) Jun;21(3):499-511. 
45 Bremmer H.J. and van Veen M.P. General Fact Sheet. To be published 
(www.consexpo.nl) 
 
 
 
 
 
 
Report 630700001  Page 67 of 71 
  
                                                                                                                                  
APPENDIX A. Aggregate Exposure to Household  
Products: Model Equations And Input Data  
 
 
In the equations below the following list of symbols is used: 
 
Aapplied amount of product applied 
Aspill amount of product spilled on hands 
Asuds amount of product contained in suds 
Cair air concentration of the chemical 
Csuds concentration of the chemical in the suds 
D (absorbed) dose of the chemical 
Dinh inhaled dose of the chemical 
dlayer thickness of the layer of spilled product on 
the skin 
fabs fraction of the substance absorbed 
KH Henry’s coefficient 
Kow octanol-water partition coefficient 
Kp skin permeability 
Mw molecular weight of the chemical 
Qinh inhalation rate 
Scontact surface area of dinnerware that comes in 
contact with foodstuff 
Shands surface area of the hands that is in contact 
with the chemical 
t exposure duration 
Vsuds volume of the suds 
Wbody body weight 
wf weight fraction of the chemical in the 
product 
σresidue surface density of the chemical residue on 
dinnerware 
 
The input data are derived from ref. 45,45 
 
Dish washer  
For the evaluation of the aggregate exposure to chemicals in household products we as-
sumed the following exposure (sub) scenarios: 
1. exposure during the preparation of suds (dermal exposure due to spillage) 
2. exposure during washing the dish (dermal and inhalation exposure) 
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3. exposure due to residues of the substance on the dish (oral exposure via food in-
take from the dinnerware) 
 
The scenarios 1 and 2 apply only to the people using the product. Scenario 3) applies also 
to non-users. Scenario 1) and the dermal contact of scenario 2) apply to users of the prod-
uct only. Inhalation exposure during scenario 2) also applies to non-users of the product 
who are in the same room where the product is used. 
The following simple model equations were used to estimate the exposures:  
1.  The amount of undiluted product spilled on hands during preparation is described 
in the TNsG45 on biocides to be 0 to 3.2 mg per event. 
A fraction wf  of this amount is the amount of chemical, of which a fraction of fabs 
is absorbed. Hence, from this the systemic dose per event is calculated as:  
spill f abs
body
A w f
D
W
× ×=  
2. The air concentration resulting from the evaporating of the substance from the 
suds is approximated by the equilibrium air concentration as predicted by Henry’s 
law: 
 
 air H sudsC K C= ×  
 
 from this, the inhaled dose is estimated as: 
 
 air inh H inhinh applied f
body suds body
C Q t K Q tD A w
W V W
× × × ×= = × × ×  
 in which it is implicitly assumed that the absorption in the respiratory tract is 
100%. 
 The dermal exposure arises from the diffusion of the substance from the solution 
through the skin. The permeability of the skin for a substance can be estimated us-
ing experimental QSARs such as the one by Potts and Guy: 
 
 log( ) 2.7 0.71 log( ) 0.0061ow wKp K M= − + × − ×  
 
 Using this value for the permeability, the dermal absorbed dose is given by: 
 
 (1 )
pK t
suds f
body suds
eA w
W V
− ×−× × ×  
 
3. The surface density of residues left on dinnerware after washing are estimated by 
HERA45 as 5.5 x 10-5 ml/ cm2 and the value for the area of dishes in daily contact 
with food as 5400 cm2. All of the residue that is in contact with the foodstuff is 
supposed to be taken up systemically. Thus: 
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contact residue
suds f
body suds
SD A w
W V
σ×= × × ×  
 
All-purpose cleaner 
For the all-purpose cleaner we assume exposure: 
1. when preparing the suds (dermal exposure due to spillage) 
2. during cleaning (inhalation exposure due to evaporation, dermal exposure due to 
rinsing of cloth in the suds and wiping with a cloth) 
As the model equations describing these scenarios we choose: 
1. The exposure during preparation is estimated similarly to scenario 1. for the expo-
sure to dish washer. 
2. During use, that is the cleaning of surfaces, the diluted product is applied in a thin 
layer. This situation (large surface in relation to the volume) highly favours the 
evaporation of the substance. It is therefore assumed that all of the applied chemi-
cal (wf x Aapplied) evaporates into the air. The air concentration is thus calculated 
as:  
applied f
air
room
A w
C
V
×=  
and the inhalation dose as: 
air inh inh
inh applied f
body room body
C Q t Q tD A w
W V W
× × ×= = × × ×  
To assess the dermal exposure we follow the assumptions made in the TGD, 
which suggest a default value for the thickness of a product layer left on the skin 
of 0.01 cm. For dermal exposure to the dilution, the amount can be calculated by 
multiplying the exposed area (cm2) with the thickness of the layer dlayer. The ex-
posure follows: 
layer hands abs
spill f
suds body
d S f
D A w
V W
× ×= × × ×  
 
Toilet cleaner 
Finally, we assume the exposure to the toilet cleaner to take place during the use of the 
product (cleaning) only. Exposure is via inhalation of evaporating substance as well as by 
dermal contact.  
 
1. the inhalation exposure is due to the evaporation of the substance from the toi-
let where it is supposed to be diluted with water. We describe the resulting air 
concentration and exposure again by the equation used in sub scenario 2 for 
the dish washer (Henry’s Law).  
2. The dermal exposure is due to accidental spilling. For this exposure we follow 
the TGD default approach, used also in scenario 2. for the all purpose cleaner 
(dermal exposure). 
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Exposure factors 
For the sub scenarios described above, we used the following values for the exposure fac-
tors to evaluate the exposure: 
 
Adult user 
parameter point estimate distribution : mean (s.d.) 
body weight (kg) 65 75 (13) 
inhalation rate (m3/hr) 1.44 - 
uptake fraction inhalation (%) 100 - 
uptake fraction oral (%) 100 - 
uptake fraction dermal (%) 10 - 
Henry’s coefficient 0.01  
dish washing 
weight fraction 0.01  
use frequency (times a year) 426 230 (288) 
amount spilled during prepara-
tion (g) 
2 0-32 
volume of suds (liter) 5 - 
exposure duration (hour) 1  
amount used (g) 70 LogNorm (30, 50) 
exposed area dish (cm2) 5400 - 
residue on dish (ml/cm2) 5.5e-5 - 
all-purpose cleaner 
weight fraction 0.01  
use frequency (times a year) 104 128, 255 
amount spilled during prepara-
tion (mg) 
2 - 
volume suds (liter) 5 - 
amount applied during use (g) 74 27, 30 
exposure duration (hr) 1 0.3, 0.4 
volume room (m3) 20 20 
thickness layer suds residue on 
skin (mm) 
0.01 - 
surface area hands (cm2) 860 - 
   
toilet cleaner 
weight fraction 0.01  
use frequency (times per year) 260 102, 206 
volume suds (liter) 5 - 
amount applied (g) 55 40, 22 
exposure duration (min) 2 1.2, 0.7 
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thickness layer suds residue on 
skin (mm) 
0.01 - 
surface area hands (cm2) 860 - 
   
 
Indirectly exposed child 
parameter point estimate distribution : mean (s.d.) 
body weight (kg) 11 11.1, 1.9 
inhalation rate (m3/hr) 0.06 - 
uptake fraction inhalation (%) 100 - 
uptake fraction oral (%) 100 - 
uptake fraction dermal (%) 10 - 
dish washing 
frequency 426 230 (288) 
exposed area dish (cm2) 5400 - 
residue on dish (ml/cm2) 5.5e-5 - 
all-purpose cleaner 
use frequency (times a year) 204 128, 255 
volume suds (liter) 5 - 
amount applied during use (g) 74 27, 30 
exposure duration (hour) 1 0.3, 0.4 
volume room (m3) 20 - 
 
 
 
